{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:30:59Z","timestamp":1793943059197,"version":"4.8.0"},"reference-count":326,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grant","doi-asserted-by":"crossref","award":["82173326"],"award-info":[{"award-number":["82173326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["24CGZHO5"],"award-info":[{"award-number":["24CGZHO5"]}]},{"name":"Natural Scinece Foundation of Sichuan Province","award":["2025ZNSFSCI1867"],"award-info":[{"award-number":["2025ZNSFSCI1867"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer pain, a highly prevalent and distressing symptom among cancer patients, has a seriously harmful effect on their life and presents a complex challenge in clinical management. Despite extensive research efforts and the existence of clinical guidelines, significant controversies persist regarding the molecular mechanisms underpinning cancer pain as well as the most effective management strategies. This review systematically delves into the neurobiological underpinnings of cancer pain, centering on the interplay of peripheral and central sensitization, cellular stress and dysfunction, as well as the crucial roles of various signaling pathways and epigenetic regulation in its pathogenesis. In terms of treatment, the fundamental strategy involves a comprehensive initial assessment of cancer pain, followed by targeted interventions based on the assessment findings. It advocates for a multimodal approach that integrates pharmacological with non\u2013pharmacological therapies. However, ongoing debates surround issues related to opioid rotation protocols and the long-term safety of opioid use. Furthermore, it underscores the underexplored potential of personalized therapies targeting molecular pathways and the need for standardized, interdisciplinary pain assessment tools. By bridging mechanistic research and clinical practice, this work potentially provides a framework for refining guideline implementation, advancing targeted therapies, and improving patient-centered care, thereby contributing to the evolution of precision oncology and holistic pain management paradigms.<\/jats:p>","DOI":"10.1186\/s43556-025-00289-0","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:02:48Z","timestamp":1751050968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cancer pain: molecular mechanisms and management"],"prefix":"10.1186","volume":"6","author":[{"given":"Wan-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"9","key":"289_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2217\/fon-2016-0423","volume":"13","author":"NJ Neufeld","year":"2017","unstructured":"Neufeld NJ, Elnahal SM, Alvarez RH. Cancer pain: a review of epidemiology, clinical quality and value impact. Fut Oncol (London, England). 2017;13(9):833\u201341. https:\/\/doi.org\/10.2217\/fon-2016-0423.","journal-title":"Fut Oncol (London, England)"},{"issue":"1","key":"289_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12885-023-11214-5","volume":"23","author":"G Joshy","year":"2023","unstructured":"Joshy G, Khalatbari-Soltani S, Soga K, Butow P, Laidsaar-Powell R, Koczwara B, et al. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer. BMC Cancer. 2023;23(1):774. https:\/\/doi.org\/10.1186\/s12885-023-11214-5.","journal-title":"BMC Cancer"},{"issue":"5","key":"289_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jpainsymman.2024.08.002","volume":"68","author":"M Frasca","year":"2024","unstructured":"Frasca M, Martinez-Tapia C, Jean C, Chanteclair A, Galvin A, Bergua V, et al. Serious health-related suffering impairs treatments and survival in older patients with cancer. J Pain Symptom Manage. 2024;68(5):506-15.e5. https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.08.002.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"289_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","volume":"160","author":"MI Bennett","year":"2019","unstructured":"Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain. 2019;160(1):38\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000001363.","journal-title":"Pain"},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"1030899","DOI":"10.3389\/fpain.2022.1030899","volume":"3","author":"R Haroun","year":"2022","unstructured":"Haroun R, Wood JN, Sikandar S. Mechanisms of cancer pain. Front Pain Res (Lausanne, Switzerland). 2022;3:1030899. https:\/\/doi.org\/10.3389\/fpain.2022.1030899.","journal-title":"Front Pain Res (Lausanne, Switzerland)"},{"issue":"6","key":"289_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s12264-023-01126-6","volume":"40","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yang W, Zhang R, Wang Y. Peripheral mechanism of cancer-induced bone pain. Neurosci Bull. 2024;40(6):815\u201330. https:\/\/doi.org\/10.1007\/s12264-023-01126-6.","journal-title":"Neurosci Bull"},{"key":"289_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jare.2021.06.006","volume":"35","author":"XQ Zheng","year":"2022","unstructured":"Zheng XQ, Wu YH, Huang JF, Wu AM. Neurophysiological mechanisms of cancer-induced bone pain. J Adv Res. 2022;35:117\u201327. https:\/\/doi.org\/10.1016\/j.jare.2021.06.006.","journal-title":"J Adv Res"},{"issue":"10","key":"289_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.mayocp.2015.08.009","volume":"90","author":"TJ Smith","year":"2015","unstructured":"Smith TJ, Saiki CB. Cancer pain management. Mayo Clin Proc. 2015;90(10):1428\u201339. https:\/\/doi.org\/10.1016\/j.mayocp.2015.08.009.","journal-title":"Mayo Clin Proc"},{"issue":"16","key":"289_CR9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1200\/jco.2013.52.4827","volume":"32","author":"JH Kwon","year":"2014","unstructured":"Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol. 2014;32(16):1727\u201333. https:\/\/doi.org\/10.1200\/jco.2013.52.4827.","journal-title":"J Clin Oncol"},{"key":"289_CR10","doi-asserted-by":"publisher","first-page":"890951","DOI":"10.3389\/fonc.2022.890951","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Cao X, Wang Q, Yang Q, Sun M, Ge L, et al. Quality assessment of cancer pain clinical practice guidelines. Front Oncol. 2022;12:890951. https:\/\/doi.org\/10.3389\/fonc.2022.890951.","journal-title":"Front Oncol"},{"issue":"34","key":"289_CR11","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1200\/jco.22.01357","volume":"40","author":"JJ Mao","year":"2022","unstructured":"Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, et al. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998\u20134024. https:\/\/doi.org\/10.1200\/jco.22.01357.","journal-title":"J Clin Oncol"},{"key":"289_CR12","unstructured":"Sawhney M, Fletcher G, Rice J, Watt-Watson J, Rawn T. Guidelines on Management of Pain in Cancer and\/or Palliative Care. 2017."},{"issue":"4","key":"289_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2217\/pmt-2017-0006","volume":"7","author":"A Lara-Solares","year":"2017","unstructured":"Lara-Solares A, Ahumada Olea M, Basantes Pinos A, Bistre Coh\u00e9n S, Bonilla Sierra P, Duarte Ju\u00e1rez ER, et al. Latin-American guidelines for cancer pain management. Pain management. 2017;7(4):287\u201398. https:\/\/doi.org\/10.2217\/pmt-2017-0006.","journal-title":"Pain management"},{"issue":"Suppl 4","key":"289_CR14","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv166\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdy152.","journal-title":"Ann Oncol"},{"key":"289_CR15","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization \u00a9 World Health Organization 2018.; 2018."},{"issue":"7","key":"289_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/jpm.2021.0438","volume":"25","author":"H Mawatari","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T, Kohara H, Yomiya K. Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese society of palliative medicine. J Palliat Med. 2022;25(7):1095\u2013114. https:\/\/doi.org\/10.1089\/jpm.2021.0438.","journal-title":"J Palliat Med"},{"key":"289_CR17","unstructured":"Swarm RA, Youngwerth JM. Adult Cancer Pain Version 1.2025 \u2014 March 12, 2025. National Comprehensive Cancer Network Web. 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pain.pdf."},{"issue":"22","key":"289_CR18","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1200\/jco.2013.49.8311","volume":"31","author":"L Barbera","year":"2013","unstructured":"Barbera L, Molloy S, Earle CC. Frequency of non-cancer-related pain in patients with cancer. J Clin Oncol. 2013;31(22):2837. https:\/\/doi.org\/10.1200\/jco.2013.49.8311.","journal-title":"J Clin Oncol"},{"key":"289_CR19","doi-asserted-by":"publisher","unstructured":"Caraceni A, Shkodra M. Cancer pain assessment and classification. Cancers. 2019;11(4). https:\/\/doi.org\/10.3390\/cancers11040510.","DOI":"10.3390\/cancers11040510"},{"issue":"10","key":"289_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nrn1914","volume":"7","author":"PW Mantyh","year":"2006","unstructured":"Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006;7(10):797\u2013809. https:\/\/doi.org\/10.1038\/nrn1914.","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"289_CR21","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.3390\/curroncol30100637","volume":"30","author":"K Shah","year":"2023","unstructured":"Shah K, Geller DA, Tohme S, Antoni M, Kallem CJ, Vodovotz Y, et al. Predictors and consequences of cancer and non-cancer-related pain in those diagnosed with primary and metastatic cancers. Current oncology (Toronto, Ont). 2023;30(10):8826\u201340. https:\/\/doi.org\/10.3390\/curroncol30100637.","journal-title":"Current oncology (Toronto, Ont)"},{"key":"289_CR22","doi-asserted-by":"publisher","first-page":"115692","DOI":"10.1016\/j.bcp.2023.115692","volume":"215","author":"RJ Shi","year":"2023","unstructured":"Shi RJ, Ke BW, Tang YL, Liang XH. Perineural invasion: a potential driver of cancer-induced pain. Biochem Pharmacol. 2023;215:115692. https:\/\/doi.org\/10.1016\/j.bcp.2023.115692.","journal-title":"Biochem Pharmacol"},{"key":"289_CR23","doi-asserted-by":"publisher","first-page":"216894","DOI":"10.1016\/j.canlet.2024.216894","volume":"591","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Rabbani SA, Babiker R, Rangraze I, Kapre S, Palakurthi SS, et al. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies. Cancer Lett. 2024;591:216894. https:\/\/doi.org\/10.1016\/j.canlet.2024.216894.","journal-title":"Cancer Lett"},{"issue":"11","key":"289_CR24","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/1759-7714.14444","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Li X, Ma Z, Zhang S, Song X, Gao H, et al. Prevalence and management of pain in lung cancer patients in northern China: a multicenter cross-sectional study. Thoracic cancer. 2022;13(11):1684\u201390. https:\/\/doi.org\/10.1111\/1759-7714.14444.","journal-title":"Thoracic cancer"},{"key":"289_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fonc.2017.00017","volume":"7","author":"U Hochberg","year":"2017","unstructured":"Hochberg U, Elgueta MF, Perez J. Interventional analgesic management of lung cancer pain. Front Oncol. 2017;7:17. https:\/\/doi.org\/10.3389\/fonc.2017.00017.","journal-title":"Front Oncol"},{"issue":"1","key":"289_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0043-1777423","volume":"44","author":"A Cuneo","year":"2024","unstructured":"Cuneo A, Murinova N. Headache management in individuals with brain tumor. Semin Neurol. 2024;44(1):74\u201389. https:\/\/doi.org\/10.1055\/s-0043-1777423.","journal-title":"Semin Neurol"},{"key":"289_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/b978-0-12-811161-1.00017-7","volume":"149","author":"KG Gwathmey","year":"2018","unstructured":"Gwathmey KG. Plexus and peripheral nerve metastasis. Handb Clin Neurol. 2018;149:257\u201379. https:\/\/doi.org\/10.1016\/b978-0-12-811161-1.00017-7.","journal-title":"Handb Clin Neurol"},{"key":"289_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2407-12-98","volume":"12","author":"FC Ho","year":"2012","unstructured":"Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer. 2012;12:98. https:\/\/doi.org\/10.1186\/1471-2407-12-98.","journal-title":"BMC Cancer"},{"issue":"12","key":"289_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/iju.14361","volume":"27","author":"N Sassa","year":"2020","unstructured":"Sassa N. Retroperitoneal tumors: review of diagnosis and management. Int J Urol. 2020;27(12):1058\u201370. https:\/\/doi.org\/10.1111\/iju.14361.","journal-title":"Int J Urol"},{"issue":"4","key":"289_CR30","doi-asserted-by":"publisher","first-page":"rjac082","DOI":"10.1093\/jscr\/rjac082","volume":"2022","author":"K Kordeni","year":"2022","unstructured":"Kordeni K, Chardalias L, Pantiora E, Massaras D, Papadopoulos K, Primetis E, et al. Retroperitoneal ganglioneuroma presenting as lower back pain. J Surg Case Rep. 2022;2022(4):rjac082. https:\/\/doi.org\/10.1093\/jscr\/rjac082.","journal-title":"J Surg Case Rep"},{"issue":"Suppl 1","key":"289_CR31","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","volume":"154","author":"P Mantyh","year":"2013","unstructured":"Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154(Suppl 1):S54-s62. https:\/\/doi.org\/10.1016\/j.pain.2013.07.044.","journal-title":"Pain"},{"key":"289_CR32","doi-asserted-by":"publisher","unstructured":"Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW. Cancer-induced bone pain: Mechanisms and models. Neuroscience letters. 2013;557 Pt A(0 0):52\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2013.08.003.","DOI":"10.1016\/j.neulet.2013.08.003"},{"key":"289_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejogrb.2019.08.020","volume":"241","author":"S Tan","year":"2019","unstructured":"Tan S, Tao Z, Bian X, Zhao Y, Wang N, Chen X, et al. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2019;241:99\u2013103. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.08.020.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"289_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13017-019-0240-7","volume":"14","author":"F Catena","year":"2019","unstructured":"Catena F, De Simone B, Coccolini F, Di Saverio S, Sartelli M, Ansaloni L. Bowel obstruction: a narrative review for all physicians. World J Emerg Surg. 2019;14:20. https:\/\/doi.org\/10.1186\/s13017-019-0240-7.","journal-title":"World J Emerg Surg"},{"issue":"12","key":"289_CR35","doi-asserted-by":"publisher","first-page":"e20233","DOI":"10.7759\/cureus.20233","volume":"13","author":"O Fleites","year":"2021","unstructured":"Fleites O, Pelenyi SS, Lee CK, Wisnik CA, Tariq A, Abdel-Khalek A, et al. Persistent small bowel obstruction due to small bowel adenocarcinoma: a case report. Cureus. 2021;13(12):e20233. https:\/\/doi.org\/10.7759\/cureus.20233.","journal-title":"Cureus"},{"issue":"3","key":"289_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0885-3924(94)90130-9","volume":"9","author":"C Ripamonti","year":"1994","unstructured":"Ripamonti C. Management of bowel obstruction in advanced cancer patients. J Pain Symptom Manage. 1994;9(3):193\u2013200. https:\/\/doi.org\/10.1016\/0885-3924(94)90130-9.","journal-title":"J Pain Symptom Manage"},{"key":"289_CR37","unstructured":"Supportive PDQ, Palliative Care Editorial B. Cancer Pain (PDQ\u00ae): Patient Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002."},{"issue":"1","key":"289_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1148\/rg.2020190089","volume":"40","author":"RD Meek","year":"2020","unstructured":"Meek RD, Mills MK, Hanrahan CJ, Beckett BR, Leake RL, Allen H, et al. Pearls and pitfalls for soft-tissue and bone biopsies: a cross-institutional review. Radiographics. 2020;40(1):266\u201390. https:\/\/doi.org\/10.1148\/rg.2020190089.","journal-title":"Radiographics"},{"issue":"6","key":"289_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic Review of Complications of Prostate Biopsy. European Urology. 2013;64(6):876\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2013.05.049.","journal-title":"European Urology."},{"issue":"1","key":"289_CR40","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1038\/s41598-023-35426-8","volume":"13","author":"D J. Ghadimi","year":"2023","unstructured":"J. Ghadimi D, Looha MA, Akbari ME, Akbari A. Predictors of postoperative pain six months after breast surgery. Sci Rep. 2023;13(1):8302. https:\/\/doi.org\/10.1038\/s41598-023-35426-8.","journal-title":"Sci Rep"},{"issue":"3","key":"289_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/bja\/89.3.409","volume":"89","author":"SJ Dolin","year":"2002","unstructured":"Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth. 2002;89(3):409\u201323.","journal-title":"Br J Anaesth"},{"issue":"2","key":"289_CR42","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/j.pmn.2023.12.001","volume":"25","author":"L Wang","year":"2024","unstructured":"Wang L, Qin F, Liu H, Lu XH, Zhen L, Li GX. Pain sensitivity and acute postoperative pain in patients undergoing abdominal surgery: the mediating roles of pain self-efficacy and pain catastrophizing. Pain Manag Nurs. 2024;25(2):e108\u201314. https:\/\/doi.org\/10.1016\/j.pmn.2023.12.001.","journal-title":"Pain Manag Nurs"},{"issue":"4","key":"289_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.redare.2022.07.005","volume":"71","author":"N Esteve-P\u00e9rez","year":"2024","unstructured":"Esteve-P\u00e9rez N, Perez-Herrero MA, Montes-Perez A, L\u00f3pez-Alvarez S. Management of acute postoperative pain: conditions to guarantee the safety and effectiveness of analgesic treatments. Rev Esp Anestesiol Reanim. 2024;71(4):304\u201316. https:\/\/doi.org\/10.1016\/j.redare.2022.07.005.","journal-title":"Rev Esp Anestesiol Reanim"},{"issue":"2","key":"289_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ca.23696","volume":"34","author":"E Sharp","year":"2021","unstructured":"Sharp E, Roberts M, \u017burada-Zieli\u0144ska A, Zurada A, Gielecki J, Tubbs RS, et al. The most commonly injured nerves at surgery: a comprehensive review. Clin Anatom (New York, NY). 2021;34(2):244\u201362. https:\/\/doi.org\/10.1002\/ca.23696.","journal-title":"Clin Anatom (New York, NY)"},{"issue":"6","key":"289_CR45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bjane.2020.10.014","volume":"71","author":"A Lopes","year":"2021","unstructured":"Lopes A, Seligman Menezes M, Antonio Moreira de Barros G. Chronic postoperative pain: ubiquitous and scarcely appraised: narrative review. Brazilian J Anesthes (Elsevier). 2021;71(6):649\u201355. https:\/\/doi.org\/10.1016\/j.bjane.2020.10.014.","journal-title":"Brazilian J Anesthes (Elsevier)"},{"issue":"1\u20132","key":"289_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pain.2003.10.007","volume":"107","author":"Y Rothemund","year":"2004","unstructured":"Rothemund Y, Gr\u00fcsser SM, Liebeskind U, Schlag PM, Flor H. Phantom phenomena in mastectomized patients and their relation to chronic and acute pre-mastectomy pain. Pain. 2004;107(1\u20132):140\u20136. https:\/\/doi.org\/10.1016\/j.pain.2003.10.007.","journal-title":"Pain"},{"issue":"1","key":"289_CR47","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/j.pain.0000000000001398","volume":"160","author":"L Mustonen","year":"2019","unstructured":"Mustonen L, Aho T, Harno H, Sipil\u00e4 R, Meretoja T, Kalso E. What makes surgical nerve injury painful? A 4-year to 9-year follow-up of patients with intercostobrachial nerve resection in women treated for breast cancer. Pain. 2019;160(1):246\u201356. https:\/\/doi.org\/10.1097\/j.pain.0000000000001398.","journal-title":"Pain"},{"key":"289_CR48","doi-asserted-by":"publisher","unstructured":"Mattar M, Umutoni F, Hassan MA, Wamburu MW, Turner R, Patton JS et al. Chemotherapy-induced peripheral neuropathy: a recent update on pathophysiology and treatment. Life (Basel, Switzerland). 2024;14(8). https:\/\/doi.org\/10.3390\/life14080991.","DOI":"10.3390\/life14080991"},{"issue":"1","key":"289_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2015.11.011","volume":"140","author":"JR Brewer","year":"2016","unstructured":"Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2016;140(1):176\u201383. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.011.","journal-title":"Gynecol Oncol"},{"key":"289_CR50","doi-asserted-by":"publisher","first-page":"112671","DOI":"10.1016\/j.biopha.2022.112671","volume":"147","author":"AD Desforges","year":"2022","unstructured":"Desforges AD, Hebert CM, Spence AL, Reid B, Dhaibar HA, Cruz-Topete D, et al. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update. Biomed Pharmacother. 2022;147:112671. https:\/\/doi.org\/10.1016\/j.biopha.2022.112671.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"289_CR51","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461\u201370. https:\/\/doi.org\/10.1016\/j.pain.2014.09.020.","journal-title":"Pain"},{"issue":"1","key":"289_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40122-017-0092-3","volume":"7","author":"V Brozou","year":"2018","unstructured":"Brozou V, Vadalouca A, Zis P. Pain in platin-induced neuropathies: a systematic review and meta-analysis. Pain Ther. 2018;7(1):105\u201319. https:\/\/doi.org\/10.1007\/s40122-017-0092-3.","journal-title":"Pain Ther"},{"issue":"21","key":"289_CR53","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1158\/0008-5472.Can-14-2060","volume":"74","author":"BM de Carvalho","year":"2014","unstructured":"de Carvalho BM, Kosturakis AK, Eng C, Wendelschafer-Crabb G, Kennedy WR, Simone DA, et al. A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Can Res. 2014;74(21):5955\u201362. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-2060.","journal-title":"Can Res"},{"key":"289_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.critrevonc.2019.04.021","volume":"139","author":"X Guo","year":"2019","unstructured":"Guo X, Sun H, Dong J, Feng Y, Li H, Zhuang R, et al. Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019;139:16\u201323. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.021.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"289_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021;9(2):385\u2013450. https:\/\/doi.org\/10.1007\/s40487-021-00168-y.","journal-title":"Oncol Ther"},{"issue":"2","key":"289_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semradonc.2023.01.002","volume":"33","author":"LM Skarf","year":"2023","unstructured":"Skarf LM, Jones KF, Meyerson JL, Abrahm JL. Pharmacologic pain management: what radiation oncologists should know. Semin Radiation Oncol. 2023;33(2):93\u2013103. https:\/\/doi.org\/10.1016\/j.semradonc.2023.01.002.","journal-title":"Semin Radiation Oncol"},{"issue":"1","key":"289_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pne2.12094","volume":"5","author":"GWY Chua","year":"2023","unstructured":"Chua GWY, Vig PS. Overview of radiotherapy-induced chronic pain in childhood cancer survivors: a narrative review. Paediatr Neonatal Pain. 2023;5(1):1\u20139. https:\/\/doi.org\/10.1002\/pne2.12094.","journal-title":"Paediatr Neonatal Pain"},{"issue":"2","key":"289_CR58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijom.2011.10.011","volume":"41","author":"A Rodr\u00edguez-Caballero","year":"2012","unstructured":"Rodr\u00edguez-Caballero A, Torres-Lagares D, Robles-Garc\u00eda M, Pach\u00f3n-Ib\u00e1\u00f1ez J, Gonz\u00e1lez-Padilla D, Guti\u00e9rrez-P\u00e9rez JL. Cancer treatment-induced oral mucositis: a critical review. Int J Oral Maxillofac Surg. 2012;41(2):225\u201338. https:\/\/doi.org\/10.1016\/j.ijom.2011.10.011.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"289_CR59","doi-asserted-by":"publisher","unstructured":"Spinato G, Schiavon V, Torvilli S, Carraro S, Amato F, Daloiso A et al. Oral Care in head and neck radiotherapy: proposal for an oral hygiene protocol. J Person Med. 2024;14(9). https:\/\/doi.org\/10.3390\/jpm14091013.","DOI":"10.3390\/jpm14091013"},{"issue":"1","key":"289_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00520-020-05462-5","volume":"29","author":"E Lam","year":"2021","unstructured":"Lam E, Wong G, Zhang L, Drost L, Karam I, Yee C, et al. Self-reported pain in breast cancer patients receiving adjuvant radiotherapy. Support Care Cancer. 2021;29(1):155\u201367. https:\/\/doi.org\/10.1007\/s00520-020-05462-5.","journal-title":"Support Care Cancer"},{"key":"289_CR61","unstructured":"Classen J, Belka C, Paulsen F, Budach W, Hoffmann W, Bamberg M. Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 1998;174 Suppl 3:82\u20134."},{"key":"289_CR62","doi-asserted-by":"publisher","first-page":"101711","DOI":"10.1016\/j.bpg.2020.101711","volume":"48\u201349","author":"A Afifi","year":"2020","unstructured":"Afifi A, Powerski M, Jechorek D, Brunner TB, Weigt J, Venerito M. Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options. Best Pract Res Clin Gastroenterol. 2020;48\u201349:101711. https:\/\/doi.org\/10.1016\/j.bpg.2020.101711.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"289_CR63","unstructured":"Majeed H, Gupta V. Adverse Effects of Radiation Therapy. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Vikas Gupta declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"issue":"7","key":"289_CR64","doi-asserted-by":"publisher","first-page":"e27138","DOI":"10.7759\/cureus.27138","volume":"14","author":"A Katano","year":"2022","unstructured":"Katano A, Minamitani M, Yamashita H, Nakagawa K. Delayed onset of pleural effusion after thoracic radiation therapy for hodgkin lymphoma: a case report with over 30-year follow-up. Cureus. 2022;14(7):e27138. https:\/\/doi.org\/10.7759\/cureus.27138.","journal-title":"Cureus"},{"issue":"1","key":"289_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13054-016-1208-6","volume":"20","author":"RM Bateman","year":"2016","unstructured":"Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Sol\u00e9-Viol\u00e1n J, L\u00f3pez-Rodr\u00edguez M, et al. 36th international symposium on intensive care and emergency medicine\u202f: Brussels, Belgium. 15-18 March 2016. Crit Care (London, England). 2016;20(1):94. https:\/\/doi.org\/10.1186\/s13054-016-1208-6.","journal-title":"Crit Care (London, England)"},{"issue":"3","key":"289_CR66","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","volume":"6","author":"AK Schreiber","year":"2015","unstructured":"Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes. 2015;6(3):432\u201344. https:\/\/doi.org\/10.4239\/wjd.v6.i3.432.","journal-title":"World J Diabetes"},{"issue":"8","key":"289_CR67","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41574-022-00710-6","volume":"18","author":"RA Malik","year":"2022","unstructured":"Malik RA. Novel mechanisms of pain in painful diabetic neuropathy. Nat Rev Endocrinol. 2022;18(8):459\u201360. https:\/\/doi.org\/10.1038\/s41574-022-00710-6.","journal-title":"Nat Rev Endocrinol"},{"issue":"16","key":"289_CR68","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/jco.2013.54.4825","volume":"32","author":"KL Syrjala","year":"2014","unstructured":"Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703\u201311. https:\/\/doi.org\/10.1200\/jco.2013.54.4825.","journal-title":"J Clin Oncol"},{"key":"289_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-99684-4_3","volume-title":"Essentials of Interventional Cancer Pain Management","author":"SL Thorp","year":"2019","unstructured":"Thorp SL. Pathophysiology of Cancer Pain. In: Gulati A, Puttanniah V, Bruel BM, Rosenberg WS, Hung JC, editors. Essentials of Interventional Cancer Pain Management. Cham: Springer International Publishing; 2019. p. 13\u20137."},{"key":"289_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-030-87266-3_40","volume-title":"Anesthesiology In-Training Exam Review: Regional Anesthesia and Chronic Pain","author":"B Schuster","year":"2022","unstructured":"Schuster B, Ness T, Sellers A. Basic Science: Pathophysiology of Acute and Chronic Pain; Somatic Versus Visceral Pain. In: Banik RK, editor. Anesthesiology In-Training Exam Review: Regional Anesthesia and Chronic Pain. Cham: Springer International Publishing; 2022. p. 207\u201311."},{"key":"289_CR71","doi-asserted-by":"publisher","first-page":"2050313x2311574","DOI":"10.1177\/2050313x231157483","volume":"11","author":"A Fern\u00e1ndez","year":"2023","unstructured":"Fern\u00e1ndez A, Rodr\u00edguez Cardona X, Cardenas Rey CJ, Moreno-Quijano C, Rodriguez Mart\u00ednez CH. Using a multimodal approach to manage difficult visceral cancer pain: a case study. SAGE Open Med Case Rep. 2023;11:2050313x231157483. https:\/\/doi.org\/10.1177\/2050313x231157483.","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"289_CR72","doi-asserted-by":"publisher","first-page":"721","DOI":"10.5535\/arm.2013.37.5.721","volume":"37","author":"HK Park","year":"2013","unstructured":"Park HK, Song DH, Kim YM, Kim HG, Kim SY, Chung ME. Intractable abdominal pain in a patient with spinal cord injury: a case report. Ann Rehabil Med. 2013;37(5):721\u20134. https:\/\/doi.org\/10.5535\/arm.2013.37.5.721.","journal-title":"Ann Rehabil Med"},{"issue":"1","key":"289_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SPC.0b013e32834f6ec9","volume":"6","author":"S Sikandar","year":"2012","unstructured":"Sikandar S, Dickenson AH. Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012;6(1):17\u201326. https:\/\/doi.org\/10.1097\/SPC.0b013e32834f6ec9.","journal-title":"Curr Opin Support Palliat Care"},{"key":"289_CR74","first-page":"273","volume-title":"Advances in Pharmacology","author":"AC Johnson","year":"2016","unstructured":"Johnson AC, Greenwood-Van MB. Chapter Ten - The Pharmacology of Visceral Pain. In: Barrett JE, editor. Advances in Pharmacology. Academic Press; 2016. p. 273\u2013301."},{"issue":"9170","key":"289_CR75","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(99)01306-9","volume":"353","author":"F Cervero","year":"1999","unstructured":"Cervero F, Laird JMA. Visceral pain. Lancet. 1999;353(9170):2145\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(99)01306-9.","journal-title":"Lancet"},{"issue":"1","key":"289_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13014-021-01764-y","volume":"16","author":"R Klaus","year":"2021","unstructured":"Klaus R, Niyazi M, Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol. 2021;16(1):43. https:\/\/doi.org\/10.1186\/s13014-021-01764-y.","journal-title":"Radiat Oncol"},{"issue":"1","key":"289_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3857\/roj.2021.00717","volume":"40","author":"D Kumar","year":"2022","unstructured":"Kumar D, Kiran NM, Khosla D. Reviewing the potential role of radiation therapy in gallbladder cancer: an update. Radiat Oncol J. 2022;40(1):1\u20138. https:\/\/doi.org\/10.3857\/roj.2021.00717.","journal-title":"Radiat Oncol J"},{"key":"289_CR78","doi-asserted-by":"crossref","unstructured":"Murphy PM. Somatic Pain. In: Gebhart GF, Schmidt RF, editors. Encyclopedia of Pain. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. p. 3525\u20137.","DOI":"10.1007\/978-3-642-28753-4_4061"},{"issue":"2","key":"289_CR79","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0973-1075.84532","volume":"17","author":"SP Kumar","year":"2011","unstructured":"Kumar SP. Cancer pain: a critical review of mechanism-based classification and physical therapy management in palliative care. Indian J Palliat Care. 2011;17(2):116\u201326. https:\/\/doi.org\/10.4103\/0973-1075.84532.","journal-title":"Indian J Palliat Care"},{"key":"289_CR80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/B978-1-4377-0150-0.10004-9","volume-title":"Diagnostic Radiology and Ultrasonography of the Dog and Cat","author":"JK Kealy","year":"2011","unstructured":"Kealy JK, McAllister H, Graham JP. CHAPTER four - Bones and Joints. In: Kealy JK, McAllister H, Graham JP, editors. Diagnostic Radiology and Ultrasonography of the Dog and Cat. 5th ed. Saint Louis: W.B. Saunders; 2011. p. 351\u2013446.","edition":"5"},{"issue":"1","key":"289_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-021-00450-y","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H, Zheng Q, Lu Z, Wang L, Ding L, Xia L, et al. Role of the nervous system in cancers: a review. Cell Death Discov. 2021;7(1):76. https:\/\/doi.org\/10.1038\/s41420-021-00450-y.","journal-title":"Cell Death Discov"},{"issue":"11","key":"289_CR82","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1002\/mco2.784","volume":"5","author":"HY Fan","year":"2024","unstructured":"Fan HY, Liang XH, Tang YL. Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk. MedComm. 2024;5(11):e784. https:\/\/doi.org\/10.1002\/mco2.784.","journal-title":"MedComm"},{"key":"289_CR83","doi-asserted-by":"publisher","unstructured":"Edwards HL, Mulvey MR, Bennett MI. Cancer-related neuropathic pain. Cancers. 2019;11(3). https:\/\/doi.org\/10.3390\/cancers11030373.","DOI":"10.3390\/cancers11030373"},{"issue":"1","key":"289_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/SPC.0b013e3283260644","volume":"3","author":"MJ Hjermstad","year":"2009","unstructured":"Hjermstad MJ, Fainsinger R, Kaasa S. Assessment and classification of cancer pain. Curr Opin Support Palliat Care. 2009;3(1):24\u201330. https:\/\/doi.org\/10.1097\/SPC.0b013e3283260644.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"4","key":"289_CR85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/2049463720972730","volume":"15","author":"J Po\u00e7o Gon\u00e7alves","year":"2021","unstructured":"Po\u00e7o Gon\u00e7alves J, Veiga D, Ara\u00fajo A. Chronic pain, functionality and quality of life in cancer survivors. Br J Pain. 2021;15(4):401\u201310. https:\/\/doi.org\/10.1177\/2049463720972730.","journal-title":"Br J Pain"},{"issue":"6","key":"289_CR86","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5114\/wo.2012.32481","volume":"16","author":"J Rudowska","year":"2012","unstructured":"Rudowska J. Management of breakthrough pain due to cancer. Contemp Oncol (Poznan, Poland). 2012;16(6):498\u2013501. https:\/\/doi.org\/10.5114\/wo.2012.32481.","journal-title":"Contemp Oncol (Poznan, Poland)"},{"key":"289_CR87","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2147\/jpr.S135807","volume":"10","author":"R Vellucci","year":"2017","unstructured":"Vellucci R, Mediati RD, Gasperoni S, Mammucari M, Marinangeli F, Romualdi P. Assessment and treatment of breakthrough cancer pain: from theory to clinical practice. J Pain Res. 2017;10:2147\u201355. https:\/\/doi.org\/10.2147\/jpr.S135807.","journal-title":"J Pain Res"},{"key":"289_CR88","doi-asserted-by":"publisher","unstructured":"Batistaki C, Graczyk M, Janecki M, Lewandowska AA, Moutinho R, Vagdatli K. Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment - case series and review of the literature. Drugs in context. 2022;11. https:\/\/doi.org\/10.7573\/dic.2022-9-4.","DOI":"10.7573\/dic.2022-9-4"},{"key":"289_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/B978-0-323-08340-9.00023-2","volume-title":"Practical Management of Pain","author":"V Sharma","year":"2014","unstructured":"Sharma V, de Leon-Casasola O. 23 - Cancer Pain. In: Benzon HT, Rathmell JP, Wu CL, Turk DC, Argoff CE, Hurley RW, editors. Practical Management of Pain. 5th ed. Philadelphia: Mosby; 2014. p. 335- 45.e3.","edition":"5"},{"issue":"3","key":"289_CR90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/20494637231208093","volume":"18","author":"K Greenfield","year":"2024","unstructured":"Greenfield K, Schoth DE, Hain R, Bailey S, Mott C, Rajapakse D, et al. A rapid systematic review of breakthrough pain definitions and descriptions. Br J Pain. 2024;18(3):215\u201326. https:\/\/doi.org\/10.1177\/20494637231208093.","journal-title":"Br J Pain"},{"issue":"6","key":"289_CR91","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/j.pain.0000000000000158","volume":"156","author":"D Fang","year":"2015","unstructured":"Fang D, Kong LY, Cai J, Li S, Liu XD, Han JS, et al. Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK\/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model. Pain. 2015;156(6):1124\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000000158.","journal-title":"Pain"},{"key":"289_CR92","doi-asserted-by":"publisher","first-page":"174480691983024","DOI":"10.1177\/1744806919830240","volume":"15","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang L, Wang H, Su Z, Pang X. Neuroinflammation and central PI3K\/Akt\/mTOR signal pathway contribute to bone cancer pain. Mol Pain. 2019;15:1744806919830240. https:\/\/doi.org\/10.1177\/1744806919830240.","journal-title":"Mol Pain"},{"key":"289_CR93","doi-asserted-by":"publisher","first-page":"174480691985798","DOI":"10.1177\/1744806919857981","volume":"15","author":"D Zhao","year":"2019","unstructured":"Zhao D, Han DF, Wang SS, Lv B, Wang X, Ma C. Roles of tumor necrosis factor-\u03b1 and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1. Mol Pain. 2019;15:1744806919857981. https:\/\/doi.org\/10.1177\/1744806919857981.","journal-title":"Mol Pain"},{"issue":"12","key":"289_CR94","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.21037\/apm-21-3471","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, Gao Y, Lin T. Expression of interleukin-1 (IL-1), IL-6, and tumor necrosis factor-\u03b1 (TNF-\u03b1) in non-small cell lung cancer and its relationship with the occurrence and prognosis of cancer pain. Ann Palliative Med. 2021;10(12):12759\u201366. https:\/\/doi.org\/10.21037\/apm-21-3471.","journal-title":"Ann Palliative Med"},{"issue":"19","key":"289_CR95","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1523\/jneurosci.4476-07.2008","volume":"28","author":"CE Constantin","year":"2008","unstructured":"Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, et al. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci. 2008;28(19):5072\u201381. https:\/\/doi.org\/10.1523\/jneurosci.4476-07.2008.","journal-title":"J Neurosci"},{"issue":"38","key":"289_CR96","doi-asserted-by":"publisher","first-page":"10289","DOI":"10.1523\/jneurosci.2851-07.2007","volume":"27","author":"IA Khasabova","year":"2007","unstructured":"Khasabova IA, Stucky CL, Harding-Rose C, Eikmeier L, Beitz AJ, Coicou LG, et al. Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J Neurosci. 2007;27(38):10289\u201398. https:\/\/doi.org\/10.1523\/jneurosci.2851-07.2007.","journal-title":"J Neurosci"},{"key":"289_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2018.07.040","volume":"835","author":"A Ebersberger","year":"2018","unstructured":"Ebersberger A. The analgesic potential of cytokine neutralization with biologicals. Eur J Pharmacol. 2018;835:19\u201330. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.040.","journal-title":"Eur J Pharmacol"},{"issue":"15\u201316","key":"289_CR98","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.lfs.2011.02.008","volume":"88","author":"M Isono","year":"2011","unstructured":"Isono M, Suzuki T, Hosono K, Hayashi I, Sakagami H, Uematsu S, et al. Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice. Life Sci. 2011;88(15\u201316):693\u2013700. https:\/\/doi.org\/10.1016\/j.lfs.2011.02.008.","journal-title":"Life Sci"},{"issue":"26","key":"289_CR99","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1523\/jneurosci.2204-18.2019","volume":"39","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wang Y, Liu Y, Han H, Zhang D, Fan X, et al. Transcriptional regulation of voltage-gated sodium channels contributes to GM-CSF-induced pain. J NeuroscI. 2019;39(26):5222\u201333. https:\/\/doi.org\/10.1523\/jneurosci.2204-18.2019.","journal-title":"J NeuroscI"},{"issue":"11","key":"289_CR100","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jpain.2005.06.010","volume":"6","author":"MA Sevcik","year":"2005","unstructured":"Sevcik MA, Ghilardi JR, Halvorson KG, Lindsay TH, Kubota K, Mantyh PW. Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model. J Pain. 2005;6(11):771\u20135. https:\/\/doi.org\/10.1016\/j.jpain.2005.06.010.","journal-title":"J Pain"},{"issue":"6","key":"289_CR101","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ejpain.2009.10.010","volume":"14","author":"M Fujita","year":"2010","unstructured":"Fujita M, Andoh T, Ohashi K, Akira A, Saiki I, Kuraishi Y. Roles of kinin B1 and B2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice. Eur J Pain (London, England). 2010;14(6):588\u201394. https:\/\/doi.org\/10.1016\/j.ejpain.2009.10.010.","journal-title":"Eur J Pain (London, England)"},{"key":"289_CR102","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuropharm.2017.04.004","volume":"127","author":"AJ Agwa","year":"2017","unstructured":"Agwa AJ, Henriques ST, Schroeder CI. Gating modifier toxin interactions with ion channels and lipid bilayers: Is the trimolecular complex real? Neuropharmacology. 2017;127:32\u201345. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.004.","journal-title":"Neuropharmacology"},{"key":"289_CR103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/B978-0-12-374248-3.00012-4","volume-title":"Neuromodulation","author":"JT Mortimer","year":"2009","unstructured":"Mortimer JT, Bhadra N. Chapter 11 - Fundamentals of Electrical Stimulation. In: Krames ES, Peckham PH, Rezai AR, editors. Neuromodulation. San Diego: Academic Press; 2009. p. 109\u201321."},{"key":"289_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-443-10321-6.00006-0","volume-title":"Clinical Neuroscience","author":"P Johns","year":"2014","unstructured":"Johns P. Chapter 6 - Electrical signalling in neurons. In: Johns P, editor. Clinical Neuroscience. Churchill Livingstone; 2014. p. 71\u201380."},{"key":"289_CR105","doi-asserted-by":"publisher","first-page":"564980","DOI":"10.3389\/fncom.2020.564980","volume":"14","author":"P Verma","year":"2020","unstructured":"Verma P, Eaton M, Kienle A, Flockerzi D, Yang Y, Ramkrishna D. Examining sodium and potassium channel conductances involved in hyperexcitability of chemotherapy-induced peripheral neuropathy: a mathematical and cell culture-based study. Front Comput Neurosci. 2020;14:564980. https:\/\/doi.org\/10.3389\/fncom.2020.564980.","journal-title":"Front Comput Neurosci"},{"issue":"5","key":"289_CR106","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpain.2018.11.001","volume":"20","author":"L Li","year":"2019","unstructured":"Li L, Li J, Zuo Y, Dang D, Frost JA, Yang Q. Activation of KCNQ channels prevents paclitaxel-induced peripheral neuropathy and associated neuropathic pain. J Pain. 2019;20(5):528\u201339. https:\/\/doi.org\/10.1016\/j.jpain.2018.11.001.","journal-title":"J Pain"},{"key":"289_CR107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tox.2018.12.003","volume":"413","author":"S Tomita","year":"2019","unstructured":"Tomita S, Sekiguchi F, Deguchi T, Miyazaki T, Ikeda Y, Tsubota M, et al. Critical role of Ca(v)3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice. Toxicology. 2019;413:33\u20139. https:\/\/doi.org\/10.1016\/j.tox.2018.12.003.","journal-title":"Toxicology"},{"key":"289_CR108","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.jbo.2023.100495","volume":"42","author":"Q Liu","year":"2023","unstructured":"Liu Q, Lu Z, Ren H, Fu L, Wang Y, Bu H, et al. Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1\/HIF-1\u03b1 signaling pathway in the rat spinal cord. J Bone Oncol. 2023;42:100495. https:\/\/doi.org\/10.1016\/j.jbo.2023.100495.","journal-title":"J Bone Oncol"},{"key":"289_CR109","doi-asserted-by":"publisher","unstructured":"Fayad SL, Ourties G, Le Gac B, Jouffre B, Lamoine S, Fruqui\u00e8re A et al. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. eLife. 2022;11. https:\/\/doi.org\/10.7554\/eLife.79018.","DOI":"10.7554\/eLife.79018"},{"issue":"5","key":"289_CR110","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2217\/pmt-2018-0020","volume":"8","author":"JA Boyette-Davis","year":"2018","unstructured":"Boyette-Davis JA, Hou S, Abdi S, Dougherty PM. An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy. Pain Manag. 2018;8(5):363\u201375. https:\/\/doi.org\/10.2217\/pmt-2018-0020.","journal-title":"Pain Manag"},{"key":"289_CR111","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fphys.2017.01040","volume":"8","author":"M Naz\u0131ro\u011flu","year":"2017","unstructured":"Naz\u0131ro\u011flu M, Braidy N. Thermo-sensitive TRP channels: novel targets for treating chemotherapy-induced peripheral pain. Front Physiol. 2017;8:1040. https:\/\/doi.org\/10.3389\/fphys.2017.01040.","journal-title":"Front Physiol"},{"key":"289_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1744-8069-6-15","volume":"6","author":"LE Ta","year":"2010","unstructured":"Ta LE, Bieber AJ, Carlton SM, Loprinzi CL, Low PA, Windebank AJ. Transient receptor potential vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain. 2010;6:15. https:\/\/doi.org\/10.1186\/1744-8069-6-15.","journal-title":"Mol Pain"},{"key":"289_CR113","doi-asserted-by":"publisher","first-page":"174185","DOI":"10.1016\/j.ejphar.2021.174185","volume":"904","author":"AS de Almeida","year":"2021","unstructured":"de Almeida AS, Bernardes LB, Trevisan G. TRP channels in cancer pain. Eur J Pharmacol. 2021;904:174185. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174185.","journal-title":"Eur J Pharmacol"},{"key":"289_CR114","doi-asserted-by":"publisher","unstructured":"Duitama M, Moreno Y, Santander SP, Casas Z, Sutachan JJ, Torres YP et al. TRP Channels as Molecular Targets to Relieve Cancer Pain. Biomolecules. 2021;12(1). https:\/\/doi.org\/10.3390\/biom12010001.","DOI":"10.3390\/biom12010001"},{"issue":"1","key":"289_CR115","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pain.2013.08.030","volume":"155","author":"RG Ungard","year":"2014","unstructured":"Ungard RG, Seidlitz EP, Singh G. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain. Pain. 2014;155(1):28\u201336. https:\/\/doi.org\/10.1016\/j.pain.2013.08.030.","journal-title":"Pain"},{"key":"289_CR116","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.1038\/srep08380","volume":"5","author":"J Fazzari","year":"2015","unstructured":"Fazzari J, Lin H, Murphy C, Ungard R, Singh G. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015;5:8380. https:\/\/doi.org\/10.1038\/srep08380.","journal-title":"Sci Rep"},{"issue":"4","key":"289_CR117","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7555\/jbr.34.20190037","volume":"34","author":"H Yi","year":"2019","unstructured":"Yi H, Talmon G, Wang J. Glutamate in cancers: from metabolism to signaling. J Biomed Res. 2019;34(4):260\u201370. https:\/\/doi.org\/10.7555\/jbr.34.20190037.","journal-title":"J Biomed Res"},{"key":"289_CR118","doi-asserted-by":"publisher","first-page":"108131","DOI":"10.1016\/j.neuropharm.2020.108131","volume":"173","author":"EE Bagley","year":"2020","unstructured":"Bagley EE, Ingram SL. Endogenous opioid peptides in the descending pain modulatory circuit. Neuropharmacology. 2020;173:108131. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108131.","journal-title":"Neuropharmacology"},{"key":"289_CR119","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Dom\u00ednguez M. Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives. Biomolecules. 2024;14(8). https:\/\/doi.org\/10.3390\/biom14080926.","DOI":"10.3390\/biom14080926"},{"key":"289_CR120","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/ijgm.S42187","volume":"7","author":"SK Lee","year":"2014","unstructured":"Lee SK, Dawson J, Lee JA, Osman G, Levitin MO, Guzel RM, et al. Management of cancer pain: 1. Wider implications of orthodox analgesics. Int J Gen Med. 2014;7:49\u201358. https:\/\/doi.org\/10.2147\/ijgm.S42187.","journal-title":"Int J Gen Med"},{"issue":"15","key":"289_CR121","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.2174\/0929867327666200806105024","volume":"28","author":"S Reyes-Long","year":"2021","unstructured":"Reyes-Long S, Alfaro-Rodr\u00edguez A, Cortes-Altamirano JL, Lara-Padilla E, Herrera-Maria E, Romero-Morelos P, et al. The mechanisms of action of botulinum toxin type A in nociceptive and neuropathic pathways in cancer pain. Curr Med Chem. 2021;28(15):2996\u20133009. https:\/\/doi.org\/10.2174\/0929867327666200806105024.","journal-title":"Curr Med Chem"},{"issue":"4","key":"289_CR122","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1476-5381.2011.01297.x","volume":"163","author":"AS Wattiez","year":"2011","unstructured":"Wattiez AS, Libert F, Privat AM, Loiodice S, Fialip J, Eschalier A, et al. Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? Br J Pharmacol. 2011;163(4):792\u2013803. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01297.x.","journal-title":"Br J Pharmacol"},{"key":"289_CR123","doi-asserted-by":"crossref","unstructured":"Sommer C. CHAPTER 3.11 - Serotonin in Pain and Pain Control. In: M\u00fcller CP, Jacobs BL, editors. Handbook of Behavioral Neuroscience. Elsevier; 2010. p. 457\u201371.","DOI":"10.1016\/S1569-7339(10)70096-5"},{"key":"289_CR124","doi-asserted-by":"publisher","first-page":"1118637","DOI":"10.3389\/fimmu.2023.1118637","volume":"14","author":"L Xiao","year":"2023","unstructured":"Xiao L, Li X, Fang C, Yu J, Chen T. Neurotransmitters: promising immune modulators in the tumor microenvironment. Front Immunol. 2023;14:1118637. https:\/\/doi.org\/10.3389\/fimmu.2023.1118637.","journal-title":"Front Immunol"},{"key":"289_CR125","doi-asserted-by":"publisher","unstructured":"Sierra A, Miron VE, Paolicelli RC, Ransohoff RM. Microglia in Health and Diseases: Integrative Hubs of the Central Nervous System (CNS). Cold Spring Harbor perspectives in biology. 2024;16(8). https:\/\/doi.org\/10.1101\/cshperspect.a041366.","DOI":"10.1101\/cshperspect.a041366"},{"issue":"1","key":"289_CR126","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-025-06296-7","volume":"23","author":"XX Zhu","year":"2025","unstructured":"Zhu XX, Wang PJ, Chao S, Tang WJ, Zhao LY, Yu LM, et al. Transcriptomic profiling identifies ferroptosis and NF-\u03baB signaling involved in \u03b1-dimorphecolic acid regulation of microglial inflammation. J Transl Med. 2025;23(1):260. https:\/\/doi.org\/10.1186\/s12967-025-06296-7.","journal-title":"J Transl Med"},{"issue":"10","key":"289_CR127","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1111\/jnc.16006","volume":"168","author":"AO Lopez-Ortiz","year":"2024","unstructured":"Lopez-Ortiz AO, Eyo UB. Astrocytes and microglia in the coordination of CNS development and homeostasis. J Neurochem. 2024;168(10):3599\u2013614. https:\/\/doi.org\/10.1111\/jnc.16006.","journal-title":"J Neurochem"},{"issue":"12","key":"289_CR128","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1007\/s11064-024-04241-6","volume":"49","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang Z, Xu F, Liu Z, Zhao Y, Yang LZ, et al. Progress of astrocyte-neuron crosstalk in central nervous system diseases. Neurochem Res. 2024;49(12):3187\u2013207. https:\/\/doi.org\/10.1007\/s11064-024-04241-6.","journal-title":"Neurochem Res"},{"issue":"12","key":"289_CR129","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/jnr.23443","volume":"92","author":"XH Jin","year":"2014","unstructured":"Jin XH, Wang LN, Zuo JL, Yang JP, Liu SL. P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain. J Neurosci Res. 2014;92(12):1690\u2013702. https:\/\/doi.org\/10.1002\/jnr.23443.","journal-title":"J Neurosci Res"},{"issue":"8","key":"289_CR130","first-page":"E1199","volume":"25","author":"P Wu","year":"2022","unstructured":"Wu P, Wu X, Zhou G, Wang Y, Liu X, Lv R, et al. P2X7 Receptor-induced bone cancer pain by regulating microglial activity via NLRP3\/IL-1beta signaling. Pain Physician. 2022;25(8):E1199\u2013210.","journal-title":"Pain Physician"},{"issue":"5","key":"289_CR131","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.labinv.2022.100054","volume":"103","author":"C Hou","year":"2023","unstructured":"Hou C, Lu M, Lei Z, Dai S, Chen W, Du S, et al. HMGB1 positive feedback loop between cancer cells and tumor-associated macrophages promotes osteosarcoma migration and invasion. Laboratory Invest. 2023;103(5):100054. https:\/\/doi.org\/10.1016\/j.labinv.2022.100054.","journal-title":"Laboratory Invest"},{"issue":"11","key":"289_CR132","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/14728222.2016.1214716","volume":"20","author":"YQ Zhou","year":"2016","unstructured":"Zhou YQ, Liu Z, Liu HQ, Liu DQ, Chen SP, Ye DW, et al. Targeting glia for bone cancer pain. Expert Opin Ther Targets. 2016;20(11):1365\u201374. https:\/\/doi.org\/10.1080\/14728222.2016.1214716.","journal-title":"Expert Opin Ther Targets"},{"key":"289_CR133","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/jpr.S498466","volume":"18","author":"X Wang","year":"2025","unstructured":"Wang X, Li L, Wang Y. Mechanisms of cancer-induced bone pain. J Pain Res. 2025;18:315\u201326. https:\/\/doi.org\/10.2147\/jpr.S498466.","journal-title":"J Pain Res"},{"key":"289_CR134","doi-asserted-by":"publisher","unstructured":"Li X, Huang Y, Bai J. Spinal astrocytes involved in the pathogenesis and treatment of neuropathic pain. 2025;19. https:\/\/doi.org\/10.3389\/fncel.2025.1547524.","DOI":"10.3389\/fncel.2025.1547524"},{"issue":"2","key":"289_CR135","doi-asserted-by":"publisher","first-page":"e70222","DOI":"10.1111\/cns.70222","volume":"31","author":"X Chen","year":"2025","unstructured":"Chen X, Zeng Y, Wang Z, Zhu J, Liu F, Zhu M, et al. NFAT1 signaling contributes to bone cancer pain by regulating IL-18 expression in spinal microglia. CNS Neurosci Ther. 2025;31(2):e70222. https:\/\/doi.org\/10.1111\/cns.70222.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"289_CR136","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1097\/j.pain.0000000000001962","volume":"161","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Deng M, Huang J, Wu J, Li Z, Xing M, et al. Microglial annexin A3 downregulation alleviates bone cancer-induced pain through inhibiting the Hif-1\u03b1\/vascular endothelial growth factor signaling pathway. Pain. 2020;161(12):2750\u201362. https:\/\/doi.org\/10.1097\/j.pain.0000000000001962.","journal-title":"Pain"},{"issue":"5","key":"289_CR137","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.immuni.2023.04.011","volume":"56","author":"F Zipp","year":"2023","unstructured":"Zipp F, Bittner S, Schafer DP. Cytokines as emerging regulators of central nervous system synapses. Immunity. 2023;56(5):914\u201325. https:\/\/doi.org\/10.1016\/j.immuni.2023.04.011.","journal-title":"Immunity"},{"issue":"3","key":"289_CR138","doi-asserted-by":"publisher","first-page":"113819","DOI":"10.1016\/j.celrep.2024.113819","volume":"43","author":"M Wang","year":"2024","unstructured":"Wang M, Chen L, He J, Xia W, Ye Z, She J. Structural insights into IL-6 signaling inhibition by therapeutic antibodies. Cell Rep. 2024;43(3):113819. https:\/\/doi.org\/10.1016\/j.celrep.2024.113819.","journal-title":"Cell Rep"},{"issue":"12","key":"289_CR139","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1016\/j.apsb.2024.09.016","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Lv X, Zhao X, Yi L, Lv N, Xu W, et al. Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice. Acta Pharmaceut Sinica B. 2024;14(12):5249\u201366. https:\/\/doi.org\/10.1016\/j.apsb.2024.09.016.","journal-title":"Acta Pharmaceut Sinica B"},{"key":"289_CR140","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fphar.2020.00436","volume":"11","author":"H Ni","year":"2020","unstructured":"Ni H, Xu M, Xie K, Fei Y, Deng H, He Q, et al. Liquiritin alleviates pain through inhibiting CXCL1\/CXCR2 signaling pathway in bone cancer pain rat. Front Pharmacol. 2020;11:436. https:\/\/doi.org\/10.3389\/fphar.2020.00436.","journal-title":"Front Pharmacol"},{"issue":"1","key":"289_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1391-2","volume":"16","author":"H Ni","year":"2019","unstructured":"Ni H, Wang Y, An K, Liu Q, Xu L, Zhu C, et al. Crosstalk between NF\u03baB-dependent astrocytic CXCL1 and neuron CXCR2 plays a role in descending pain facilitation. J Neuroinflammation. 2019;16(1):1. https:\/\/doi.org\/10.1186\/s12974-018-1391-2.","journal-title":"J Neuroinflammation"},{"key":"289_CR142","doi-asserted-by":"publisher","first-page":"117301","DOI":"10.1016\/j.lfs.2020.117301","volume":"243","author":"Z Li","year":"2020","unstructured":"Li Z, Zhang X, Jin T, Hao J. Nicotine promotes activation of human pancreatic stellate cells through inducing autophagy via \u03b17nAChR-mediated JAK2\/STAT3 signaling pathway. Life Sci. 2020;243:117301. https:\/\/doi.org\/10.1016\/j.lfs.2020.117301.","journal-title":"Life Sci"},{"issue":"10","key":"289_CR143","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1007\/s12035-021-02458-y","volume":"58","author":"M Liu","year":"2021","unstructured":"Liu M, Cheng X, Yan H, Chen J, Liu C, Chen Z. MiR-135-5p alleviates bone cancer pain by regulating astrocyte-mediated neuroinflammation in spinal cord through JAK2\/STAT3 signaling pathway. Mol Neurobiol. 2021;58(10):4802\u201315. https:\/\/doi.org\/10.1007\/s12035-021-02458-y.","journal-title":"Mol Neurobiol"},{"key":"289_CR144","doi-asserted-by":"publisher","first-page":"174480691879323","DOI":"10.1177\/1744806918793232","volume":"14","author":"SP Chen","year":"2018","unstructured":"Chen SP, Sun J, Zhou YQ, Cao F, Braun C, Luo F, et al. Sinomenine attenuates cancer-induced bone pain via suppressing microglial JAK2\/STAT3 and neuronal CAMKII\/CREB cascades in rat models. Mol Pain. 2018;14:1744806918793232. https:\/\/doi.org\/10.1177\/1744806918793232.","journal-title":"Mol Pain"},{"issue":"6","key":"289_CR145","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/aps.2016.1","volume":"37","author":"ZP Song","year":"2016","unstructured":"Song ZP, Xiong BR, Guan XH, Cao F, Manyande A, Zhou YQ, et al. Minocycline attenuates bone cancer pain in rats by inhibiting NF-\u03baB in spinal astrocytes. Acta Pharmacol Sin. 2016;37(6):753\u201362. https:\/\/doi.org\/10.1038\/aps.2016.1.","journal-title":"Acta Pharmacol Sin"},{"key":"289_CR146","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-11-38","volume":"11","author":"J Xu","year":"2014","unstructured":"Xu J, Zhu MD, Zhang X, Tian H, Zhang JH, Wu XB, et al. NF\u03baB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice. J Neuroinflammation. 2014;11:38. https:\/\/doi.org\/10.1186\/1742-2094-11-38.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"289_CR147","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-017-0988-1","volume":"14","author":"XF Hu","year":"2017","unstructured":"Hu XF, He XT, Zhou KX, Zhang C, Zhao WJ, Zhang T, et al. The analgesic effects of triptolide in the bone cancer pain rats via inhibiting the upregulation of HDACs in spinal glial cells. J Neuroinflammation. 2017;14(1):213. https:\/\/doi.org\/10.1186\/s12974-017-0988-1.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"289_CR148","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/aln.0000000000000856","volume":"123","author":"H Song","year":"2015","unstructured":"Song H, Han Y, Pan C, Deng X, Dai W, Hu L, et al. Activation of adenosine monophosphate-activated protein kinase suppresses neuroinflammation and ameliorates bone cancer pain: involvement of inhibition on mitogen-activated protein kinase. Anesthesiology. 2015;123(5):1170\u201385. https:\/\/doi.org\/10.1097\/aln.0000000000000856.","journal-title":"Anesthesiology"},{"key":"289_CR149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1744-8069-7-48","volume":"7","author":"LN Wang","year":"2011","unstructured":"Wang LN, Yao M, Yang JP, Peng J, Peng Y, Li CF, et al. Cancer-induced bone pain sequentially activates the ERK\/MAPK pathway in different cell types in the rat spinal cord. Mol Pain. 2011;7:48. https:\/\/doi.org\/10.1186\/1744-8069-7-48.","journal-title":"Mol Pain"},{"issue":"3","key":"289_CR150","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/jnc.13139","volume":"134","author":"X Guan","year":"2015","unstructured":"Guan X, Fu Q, Xiong B, Song Z, Shu B, Bu H, et al. Activation of PI3K\u03b3\/Akt pathway mediates bone cancer pain in rats. J Neurochem. 2015;134(3):590\u2013600. https:\/\/doi.org\/10.1111\/jnc.13139.","journal-title":"J Neurochem"},{"key":"289_CR151","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2014.12.043","volume":"1599","author":"D Jin","year":"2015","unstructured":"Jin D, Yang JP, Hu JH, Wang LN, Zuo JL. MCP-1 stimulates spinal microglia via PI3K\/Akt pathway in bone cancer pain. Brain Res. 2015;1599:158\u201367. https:\/\/doi.org\/10.1016\/j.brainres.2014.12.043.","journal-title":"Brain Res"},{"issue":"1","key":"289_CR152","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Y, Oyang L, Cui S, Li S, Li J, et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell death discovery. 2024;10(1):343. https:\/\/doi.org\/10.1038\/s41420-024-02110-3.","journal-title":"Cell death discovery"},{"issue":"1","key":"289_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/boc.201800050","volume":"111","author":"E Madden","year":"2019","unstructured":"Madden E, Logue SE, Healy SJ, Manie S, Samali A. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol Cell. 2019;111(1):1\u201317. https:\/\/doi.org\/10.1111\/boc.201800050.","journal-title":"Biol Cell"},{"issue":"1","key":"289_CR154","doi-asserted-by":"publisher","first-page":"119869","DOI":"10.1016\/j.bbamcr.2024.119869","volume":"1872","author":"H Liao","year":"2025","unstructured":"Liao H, Liu S, Ma Q, Huang H, Goel A, Torabian P, et al. Endoplasmic reticulum stress induced autophagy in cancer and its potential interactions with apoptosis and ferroptosis. Biochim Biophys Acta. 2025;1872(1):119869. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119869.","journal-title":"Biochim Biophys Acta"},{"key":"289_CR155","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fcell.2020.00269","volume":"8","author":"TT Lin","year":"2020","unstructured":"Lin TT, Qu J, Wang CY, Yang X, Hu F, Hu L, et al. Rescue of HSP70 in spinal neurons alleviates opioids-induced hyperalgesia via the suppression of endoplasmic reticulum stress in rodents. Front Cell Dev Biol. 2020;8:269. https:\/\/doi.org\/10.3389\/fcell.2020.00269.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"289_CR156","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell. 2017;168(4):692\u2013706. https:\/\/doi.org\/10.1016\/j.cell.2016.12.004.","journal-title":"Cell"},{"issue":"3","key":"289_CR157","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/onc.2015.108","volume":"35","author":"M Zanetti","year":"2016","unstructured":"Zanetti M, Rodvold JJ, Mahadevan NR. The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells. Oncogene. 2016;35(3):269\u201378. https:\/\/doi.org\/10.1038\/onc.2015.108.","journal-title":"Oncogene"},{"key":"289_CR158","doi-asserted-by":"publisher","unstructured":"Sisinni L, Pietrafesa M, Lepore S, Maddalena F, Condelli V, Esposito F et al. Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int J Mol Sci. 2019;20(4). https:\/\/doi.org\/10.3390\/ijms20040857.","DOI":"10.3390\/ijms20040857"},{"issue":"3","key":"289_CR159","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pain.2011.12.011","volume":"153","author":"WH Xiao","year":"2012","unstructured":"Xiao WH, Bennett GJ. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain. 2012;153(3):704\u20139. https:\/\/doi.org\/10.1016\/j.pain.2011.12.011.","journal-title":"Pain"},{"issue":"10","key":"289_CR160","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jpain.2015.06.008","volume":"16","author":"LA Griffiths","year":"2015","unstructured":"Griffiths LA, Flatters SJ. Pharmacological modulation of the mitochondrial electron transport chain in paclitaxel-induced painful peripheral neuropathy. J Pain. 2015;16(10):981\u201394. https:\/\/doi.org\/10.1016\/j.jpain.2015.06.008.","journal-title":"J Pain"},{"issue":"9","key":"289_CR161","doi-asserted-by":"publisher","first-page":"e25212","DOI":"10.1371\/journal.pone.0025212","volume":"6","author":"M Fidanboylu","year":"2011","unstructured":"Fidanboylu M, Griffiths LA, Flatters SJ. Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS ONE. 2011;6(9):e25212. https:\/\/doi.org\/10.1371\/journal.pone.0025212.","journal-title":"PLoS ONE"},{"key":"289_CR162","doi-asserted-by":"publisher","unstructured":"Galley HF, McCormick B, Wilson KL, Lowes DA, Colvin L, Torsney C. Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. J Pineal Res. 2017;63(4). https:\/\/doi.org\/10.1111\/jpi.12444.","DOI":"10.1111\/jpi.12444"},{"issue":"6","key":"289_CR163","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5483\/bmbrep.2018.51.6.232","volume":"51","author":"YK Lee","year":"2018","unstructured":"Lee YK, Yi EY, Park SY, Jang WJ, Han YS, Jegal ME, et al. Mitochondrial dysfunction suppresses p53 expression via calcium-mediated nuclear factor-kB signaling in HCT116 human colorectal carcinoma cells. BMB Rep. 2018;51(6):296\u2013301. https:\/\/doi.org\/10.5483\/bmbrep.2018.51.6.232.","journal-title":"BMB Rep"},{"key":"289_CR164","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.redox.2018.10.012","volume":"20","author":"H Li","year":"2019","unstructured":"Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, et al. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3\u03b2-p53 signalling pathway. Redox Biol. 2019;20:261\u201374. https:\/\/doi.org\/10.1016\/j.redox.2018.10.012.","journal-title":"Redox Biol"},{"key":"289_CR165","doi-asserted-by":"publisher","unstructured":"Goodson HV, Jonasson EM. Microtubules and Microtubule-Associated Proteins. Cold Spring Harbor perspectives in biology. 2018;10(6). https:\/\/doi.org\/10.1101\/cshperspect.a022608.","DOI":"10.1101\/cshperspect.a022608"},{"issue":"7","key":"289_CR166","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ncb3188","volume":"17","author":"M Wieczorek","year":"2015","unstructured":"Wieczorek M, Bechstedt S, Chaaban S, Brouhard GJ. Microtubule-associated proteins control the kinetics of microtubule nucleation. Nat Cell Biol. 2015;17(7):907\u201316. https:\/\/doi.org\/10.1038\/ncb3188.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"289_CR167","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/syn.20841","volume":"65","author":"J Gardiner","year":"2011","unstructured":"Gardiner J, Overall R, Marc J. The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signaling. Synapse (New York, NY). 2011;65(3):249\u201356. https:\/\/doi.org\/10.1002\/syn.20841.","journal-title":"Synapse (New York, NY)"},{"issue":"1","key":"289_CR168","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s42003-023-04779-1","volume":"6","author":"CD Velasco","year":"2023","unstructured":"Velasco CD, Santarella-Mellwig R, Schorb M, Gao L, Thorn-Seshold O, Llobet A. Microtubule depolymerization contributes to spontaneous neurotransmitter release in vitro. Commun Biol. 2023;6(1):488. https:\/\/doi.org\/10.1038\/s42003-023-04779-1.","journal-title":"Commun Biol"},{"issue":"2","key":"289_CR169","doi-asserted-by":"publisher","first-page":"112913","DOI":"10.1016\/j.yexcr.2021.112913","volume":"409","author":"W Ding","year":"2021","unstructured":"Ding W, Lu Y, Zhou A, Chen Y, Wang Z, Wang L, et al. Mast1 mediates radiation-induced gastric injury via the P38 MAPK pathway. Exp Cell Res. 2021;409(2):112913. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112913.","journal-title":"Exp Cell Res"},{"key":"289_CR170","doi-asserted-by":"publisher","unstructured":"Chen YC, Takada M, Nagornyuk A, Muhan W, Yamada H, Nagashima T et al. Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells. bioRxiv : the preprint server for biology. 2024. https:\/\/doi.org\/10.1101\/2024.11.04.621816.","DOI":"10.1101\/2024.11.04.621816"},{"key":"289_CR171","doi-asserted-by":"publisher","first-page":"217483","DOI":"10.1016\/j.canlet.2025.217483","volume":"612","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cheng L, Yang J, Xu F, Qi W, Liao K, et al. Tumor-nerve interactions in cancer regulation and progression. Cancer Lett. 2025;612:217483. https:\/\/doi.org\/10.1016\/j.canlet.2025.217483.","journal-title":"Cancer Lett"},{"issue":"1","key":"289_CR172","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"289_CR173","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT, Zhao L, Zhao KN. The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 2015;14:87. https:\/\/doi.org\/10.1186\/s12943-015-0361-x.","journal-title":"Mol Cancer"},{"issue":"23","key":"289_CR174","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1200\/jco.2011.39.7356","volume":"30","author":"NL Busaidy","year":"2012","unstructured":"Busaidy NL, Farooki A, Dowlati A, Perentesis JP, Dancey JE, Doyle LA, et al. Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway. J Clin Oncol. 2012;30(23):2919\u201328. https:\/\/doi.org\/10.1200\/jco.2011.39.7356.","journal-title":"J Clin Oncol"},{"key":"289_CR175","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"289_CR176","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/annonc\/mds333","volume":"24","author":"EM de Kruijf","year":"2013","unstructured":"de Kruijf EM, Dekker TJA, Hawinkels L, Putter H, Smit V, Kroep JR, et al. The prognostic role of TGF-\u03b2 signaling pathway in breast cancer patients. Ann Oncol. 2013;24(2):384\u201390. https:\/\/doi.org\/10.1093\/annonc\/mds333.","journal-title":"Ann Oncol"},{"issue":"4","key":"289_CR177","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1053\/j.gastro.2011.07.048","volume":"141","author":"BR Achyut","year":"2011","unstructured":"Achyut BR, Yang L. Transforming growth factor-\u03b2 in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141(4):1167\u201378. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.048.","journal-title":"Gastroenterology"},{"issue":"1","key":"289_CR178","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, Ten Dijke P. Targeting TGF-\u03b2 signaling in cancer. Trends Cancer. 2017;3(1):56\u201371. https:\/\/doi.org\/10.1016\/j.trecan.2016.11.008.","journal-title":"Trends Cancer"},{"issue":"34","key":"289_CR179","doi-asserted-by":"publisher","first-page":"e2402327","DOI":"10.1002\/advs.202402327","volume":"11","author":"K Liu","year":"2024","unstructured":"Liu K, Tian F, Chen X, Liu B, Tian S, Hou Y, et al. Stabilization of TGF-\u03b2 Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-\u03b2 Signaling Pathway to Maintain Liver Cancer Stemness and Drug Resistance. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2024;11(34):e2402327. https:\/\/doi.org\/10.1002\/advs.202402327.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"289_CR180","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/j.pain.0000000000002014","volume":"162","author":"H Duan","year":"2021","unstructured":"Duan H, Shen F, Li L, Tu Z, Chen P, Chen P, et al. Activation of the Notch signaling pathway in the anterior cingulate cortex is involved in the pathological process of neuropathic pain. Pain. 2021;162(1):263\u201374. https:\/\/doi.org\/10.1097\/j.pain.0000000000002014.","journal-title":"Pain"},{"issue":"1","key":"289_CR181","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, Kaur B, Han H, Yu J. The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol. 2023;16(1):45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z.","journal-title":"J Hematol Oncol"},{"issue":"22","key":"289_CR182","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1158\/0008-5472.Can-14-0816","volume":"74","author":"L Han","year":"2014","unstructured":"Han L, Diehl A, Nguyen NK, Korangath P, Teo W, Cho S, et al. The Notch pathway inhibits TGF\u03b2 signaling in breast cancer through HEYL-mediated crosstalk. Can Res. 2014;74(22):6509\u201318. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0816.","journal-title":"Can Res"},{"issue":"10","key":"289_CR183","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","volume":"20","author":"EM Michalak","year":"2019","unstructured":"Michalak EM, Burr ML, Bannister AJ, Dawson MA. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol. 2019;20(10):573\u201389. https:\/\/doi.org\/10.1038\/s41580-019-0143-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"289_CR184","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1038\/ncomms8091","volume":"6","author":"G Amabile","year":"2015","unstructured":"Amabile G, Di Ruscio A, M\u00fcller F, Welner RS, Yang H, Ebralidze AK, et al. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun. 2015;6:7091. https:\/\/doi.org\/10.1038\/ncomms8091.","journal-title":"Nat Commun"},{"issue":"18","key":"289_CR185","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1158\/1078-0432.Ccr-14-0901","volume":"20","author":"CT Viet","year":"2014","unstructured":"Viet CT, Dang D, Ye Y, Ono K, Campbell RR, Schmidt BL. Demethylating drugs as novel analgesics for cancer pain. Clin Cancer Res. 2014;20(18):4882\u201393. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0901.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"289_CR186","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13041-021-00854-y","volume":"14","author":"Y Katsuda","year":"2021","unstructured":"Katsuda Y, Tanaka K, Mori T, Narita M, Takeshima H, Kondo T, et al. Histone modification of pain-related gene expression in spinal cord neurons under a persistent postsurgical pain-like state by electrocautery. Mol Brain. 2021;14(1):146. https:\/\/doi.org\/10.1186\/s13041-021-00854-y.","journal-title":"Mol Brain"},{"key":"289_CR187","doi-asserted-by":"publisher","first-page":"688322","DOI":"10.3389\/fphys.2021.688322","volume":"12","author":"N Wang","year":"2021","unstructured":"Wang N, Peng YJ, Su X, Prabhakar NR, Nanduri J. Histone deacetylase 5 is an early epigenetic regulator of intermittent hypoxia induced sympathetic nerve activation and blood pressure. Front Physiol. 2021;12:688322. https:\/\/doi.org\/10.3389\/fphys.2021.688322.","journal-title":"Front Physiol"},{"issue":"1","key":"289_CR188","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13073-021-00871-5","volume":"13","author":"B Yao","year":"2021","unstructured":"Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, et al. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med. 2021;13(1):58. https:\/\/doi.org\/10.1186\/s13073-021-00871-5.","journal-title":"Genome Med"},{"issue":"10","key":"289_CR189","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1593\/neo.11048","volume":"13","author":"G Toyokawa","year":"2011","unstructured":"Toyokawa G, Cho HS, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, et al. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia (New York, NY). 2011;13(10):887\u201398. https:\/\/doi.org\/10.1593\/neo.11048.","journal-title":"Neoplasia (New York, NY)"},{"issue":"9","key":"289_CR190","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/j.pain.0000000000000971","volume":"158","author":"J Gandla","year":"2017","unstructured":"Gandla J, Lomada SK, Lu J, Kuner R, Bali KK. miR-34c-5p functions as pronociceptive microRNA in cancer pain by targeting Cav2.3 containing calcium channels. Pain. 2017;158(9):1765\u201379. https:\/\/doi.org\/10.1097\/j.pain.0000000000000971.","journal-title":"Pain"},{"issue":"10","key":"289_CR191","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s12031-020-01607-7","volume":"70","author":"M Zhu","year":"2020","unstructured":"Zhu M, Wang L, Zhu J, Xu H, Wei K, Chen Q, et al. MicroRNA-330 directs downregulation of the GABA(B)R2 in the pathogenesis of pancreatic cancer pain. J Mol Neurosci. 2020;70(10):1541\u201351. https:\/\/doi.org\/10.1007\/s12031-020-01607-7.","journal-title":"J Mol Neurosci"},{"key":"289_CR192","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neures.2019.09.002","volume":"158","author":"T Xie","year":"2020","unstructured":"Xie T, Zhang J, Kang Z, Liu F, Lin Z. miR-101 down-regulates mTOR expression and attenuates neuropathic pain in chronic constriction injury rat models. Neurosci Res. 2020;158:30\u20136. https:\/\/doi.org\/10.1016\/j.neures.2019.09.002.","journal-title":"Neurosci Res"},{"issue":"3","key":"289_CR193","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3322\/caac.20112","volume":"61","author":"JA Paice","year":"2011","unstructured":"Paice JA, Ferrell B. The management of cancer pain. CA A Cancer J Clin. 2011;61(3):157\u201382. https:\/\/doi.org\/10.3322\/caac.20112.","journal-title":"CA A Cancer J Clin"},{"issue":"3","key":"289_CR194","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21453","volume":"68","author":"BM Scarborough","year":"2018","unstructured":"Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA A Cancer J Clin. 2018;68(3):182\u201396. https:\/\/doi.org\/10.3322\/caac.21453.","journal-title":"CA A Cancer J Clin"},{"issue":"5 Suppl","key":"289_CR195","doi-asserted-by":"publisher","first-page":"702","DOI":"10.6004\/jnccn.2013.0206","volume":"11","author":"RA Swarm","year":"2013","unstructured":"Swarm RA. The management of pain in patients with cancer. J Natl Comprehens Cancer Net. 2013;11(5 Suppl):702\u20134. https:\/\/doi.org\/10.6004\/jnccn.2013.0206.","journal-title":"J Natl Comprehens Cancer Net"},{"issue":"11","key":"289_CR196","doi-asserted-by":"publisher","first-page":"758","DOI":"10.31128\/ajgp-07-18-4629","volume":"47","author":"J Yoong","year":"2018","unstructured":"Yoong J, Poon P. Principles of cancer pain management: An overview and focus on pharmacological and interventional strategies. Aust J Gen Pract. 2018;47(11):758\u201362. https:\/\/doi.org\/10.31128\/ajgp-07-18-4629.","journal-title":"Aust J Gen Pract"},{"issue":"2","key":"289_CR197","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0973-1075.84531","volume":"17","author":"SP Kumar","year":"2011","unstructured":"Kumar SP. Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care. 2011;17(2):108\u201315. https:\/\/doi.org\/10.4103\/0973-1075.84531.","journal-title":"Indian J Palliat Care"},{"issue":"16","key":"289_CR198","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1200\/jco.2013.52.2508","volume":"32","author":"D Hui","year":"2014","unstructured":"Hui D, Bruera E. A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol. 2014;32(16):1640\u20136. https:\/\/doi.org\/10.1200\/jco.2013.52.2508.","journal-title":"J Clin Oncol"},{"issue":"1","key":"289_CR199","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jpain.2013.09.011","volume":"15","author":"C Brunelli","year":"2014","unstructured":"Brunelli C, Kaasa S, Knudsen AK, Hjermstad MJ, Pigni A, Caraceni A. Comparisons of patient and physician assessment of pain-related domains in cancer pain classification: results from a large international multicenter study. J Pain. 2014;15(1):59\u201367. https:\/\/doi.org\/10.1016\/j.jpain.2013.09.011.","journal-title":"J Pain"},{"issue":"5","key":"289_CR200","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/bja\/aet589","volume":"112","author":"C Price","year":"2014","unstructured":"Price C, Lee J, Taylor AM, Baranowski AP. Initial assessment and management of pain: a pathway for care developed by the British Pain Society. Br J Anaesth. 2014;112(5):816\u201323. https:\/\/doi.org\/10.1093\/bja\/aet589.","journal-title":"Br J Anaesth"},{"issue":"3","key":"289_CR201","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pec.2014.11.003","volume":"98","author":"R Adam","year":"2015","unstructured":"Adam R, Bond C, Murchie P. Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials. Patient Educ Counseling. 2015;98(3):269\u201382. https:\/\/doi.org\/10.1016\/j.pec.2014.11.003.","journal-title":"Patient Educ Counseling"},{"key":"289_CR202","doi-asserted-by":"publisher","unstructured":"Bandieri E, Potenza L, Efficace F, Bruera E, Luppi M. Independent Research on Cancer Pain Management in the Setting of Early Palliative Care: A Flywheel to Counteract General Opioid Misuse and Abuse. International journal of environmental research and public health. 2020;17(19). https:\/\/doi.org\/10.3390\/ijerph17197097.","DOI":"10.3390\/ijerph17197097"},{"issue":"3","key":"289_CR203","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/jpm.2014.0021","volume":"18","author":"SN Lim","year":"2015","unstructured":"Lim SN, Han HS, Lee KH, Lee SC, Kim J, Yun J, et al. A satisfaction survey on cancer pain management using a self-reporting pain assessment tool. J Palliat Med. 2015;18(3):225\u201331. https:\/\/doi.org\/10.1089\/jpm.2014.0021.","journal-title":"J Palliat Med"},{"key":"289_CR204","doi-asserted-by":"crossref","unstructured":"Bennett MI, Kaasa S, Barke A, Korwisi B, Rief W, Treede R-D et al. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. PAIN. 2019;160(1).","DOI":"10.1097\/j.pain.0000000000001363"},{"issue":"16","key":"289_CR205","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/jco.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32(16):1647\u201354. https:\/\/doi.org\/10.1200\/jco.2013.51.7219.","journal-title":"J Clin Oncol"},{"issue":"1","key":"289_CR206","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aet208","volume":"111","author":"MT Fallon","year":"2013","unstructured":"Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105\u201311. https:\/\/doi.org\/10.1093\/bja\/aet208.","journal-title":"Br J Anaesth"},{"issue":"8","key":"289_CR207","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","volume":"17","author":"RA Swarm","year":"2019","unstructured":"Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Comprehens Cancer Net. 2019;17(8):977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038.","journal-title":"J Natl Comprehens Cancer Net"},{"key":"289_CR208","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-1-4377-0721-2.00022-2","volume-title":"Pain Management","author":"DJ Correll","year":"2011","unstructured":"Correll DJ. Chapter 22 - The Measurement of Pain: Objectifying the Subjective. In: Waldman SD, editor. Pain Management. 2nd ed. Philadelphia: W.B. Saunders; 2011. p. 191\u2013201.","edition":"2"},{"key":"289_CR209","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-443-10310-0.00013-7","volume-title":"Headache, Orofacial Pain and Bruxism","author":"K Niere","year":"2009","unstructured":"Niere K. Chapter 13 - Measurement of headache. In: Selvaratnam P, Niere K, Zuluaga M, Friedmann S, Sloan C, Byrne E, editors. Headache, Orofacial Pain and Bruxism. Edinburgh: Churchill Livingstone; 2009. p. 153\u201365."},{"issue":"30","key":"289_CR210","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/jco.2012.41.7238","volume":"30","author":"DR Pachman","year":"2012","unstructured":"Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30(30):3687\u201396. https:\/\/doi.org\/10.1200\/jco.2012.41.7238.","journal-title":"J Clin Oncol"},{"key":"289_CR211","doi-asserted-by":"publisher","unstructured":"Keefe FJ, Abernethy AP, L CC. Psychological approaches to understanding and treating disease-related pain. Annual review of psychology. 2005;56:601\u201330. https:\/\/doi.org\/10.1146\/annurev.psych.56.091103.070302.","DOI":"10.1146\/annurev.psych.56.091103.070302"},{"issue":"22","key":"289_CR212","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1001\/jama.284.22.2907","volume":"284","author":"W Breitbart","year":"2000","unstructured":"Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284(22):2907\u201311. https:\/\/doi.org\/10.1001\/jama.284.22.2907.","journal-title":"JAMA"},{"issue":"2","key":"289_CR213","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0304-3959(01)00314-1","volume":"93","author":"CL Hicks","year":"2001","unstructured":"Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The faces pain scale \u2013 revised: toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173\u201383. https:\/\/doi.org\/10.1016\/S0304-3959(01)00314-1.","journal-title":"Pain"},{"issue":"1","key":"289_CR214","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphys.2015.07.001","volume":"62","author":"N Poquet","year":"2016","unstructured":"Poquet N, Lin C. The Brief Pain Inventory (BPI). J Physiother. 2016;62(1):52. https:\/\/doi.org\/10.1016\/j.jphys.2015.07.001.","journal-title":"J Physiother"},{"issue":"5","key":"289_CR215","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.pmn.2020.03.007","volume":"21","author":"C Scher","year":"2020","unstructured":"Scher C, Petti E, Meador L, Van Cleave JH, Liang E, Reid MC. Multidimensional pain assessment tools for ambulatory and inpatient nursing practice. Pain Manag Nurs. 2020;21(5):416\u201322. https:\/\/doi.org\/10.1016\/j.pmn.2020.03.007.","journal-title":"Pain Manag Nurs"},{"issue":"3","key":"289_CR216","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1188\/17.Onf.329-336","volume":"44","author":"A Cutillo","year":"2017","unstructured":"Cutillo A, O\u2019Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The distress thermometer: cutoff points and clinical use. Oncol Nurs Forum. 2017;44(3):329\u201336. https:\/\/doi.org\/10.1188\/17.Onf.329-336.","journal-title":"Oncol Nurs Forum"},{"key":"289_CR217","doi-asserted-by":"crossref","unstructured":"Cheung RYM. Patient Health Questionnaire-9 (PHQ-9). Handbook of Assessment in Mindfulness Research. 2023. p. 1\u201311.","DOI":"10.1007\/978-3-030-77644-2_63-1"},{"key":"289_CR218","doi-asserted-by":"crossref","unstructured":"Han ZR, Fang H, Ahemaitijiang N, Wang H. Generalized Anxiety Disorder Scale (GAD-7). Handbook of Assessment in Mindfulness Research. 2024. p. 1\u201316.","DOI":"10.1007\/978-3-030-77644-2_87-1"},{"issue":"4","key":"289_CR219","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jpainsymman.2013.10.026","volume":"48","author":"K Webber","year":"2014","unstructured":"Webber K, Davies AN, Zeppetella G, Cowie MR. Development and Validation of the Breakthrough Pain Assessment Tool (BAT) in cancer patients. J Pain Symptom Manag. 2014;48(4):619\u201331. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.10.026.","journal-title":"J Pain Symptom Manag"},{"issue":"27","key":"289_CR220","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/jco.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(27):3325\u201345. https:\/\/doi.org\/10.1200\/jco.2016.68.5206.","journal-title":"J Clin Oncol"},{"key":"289_CR221","volume-title":"Cancer pain relief","author":"World Health O","year":"1986","unstructured":"World Health O. Cancer pain relief. Geneva: World Health Organization; 1986."},{"issue":"11","key":"289_CR222","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.mpaic.2013.08.007","volume":"14","author":"M Burwaiss","year":"2013","unstructured":"Burwaiss M, Comerford D. Techniques of opioid administration. Anaesthes Intens Care Med. 2013;14(11):491\u20135. https:\/\/doi.org\/10.1016\/j.mpaic.2013.08.007.","journal-title":"Anaesthes Intens Care Med"},{"issue":"9784","key":"289_CR223","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","volume":"377","author":"RK Portenoy","year":"2011","unstructured":"Portenoy RK. Treatment of cancer pain. Lancet. 2011;377(9784):2236\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(11)60236-5.","journal-title":"Lancet"},{"issue":"7","key":"289_CR224","doi-asserted-by":"publisher","first-page":"Cd012638","DOI":"10.1002\/14651858.CD012638.pub2","volume":"7","author":"S Derry","year":"2017","unstructured":"Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev. 2017;7(7):Cd012638. https:\/\/doi.org\/10.1002\/14651858.CD012638.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"289_CR225","doi-asserted-by":"publisher","first-page":"Cd012637","DOI":"10.1002\/14651858.CD012637.pub2","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Derry S, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database syst Rev. 2017;7(7):Cd012637. https:\/\/doi.org\/10.1002\/14651858.CD012637.pub2.","journal-title":"Cochrane Database syst Rev"},{"key":"289_CR226","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejphar.2018.06.008","volume":"833","author":"A Shinohara","year":"2018","unstructured":"Shinohara A, Andoh T, Saiki I, Kuraishi Y. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice. Eur J Pharmacol. 2018;833:275\u201382. https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.008.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"289_CR227","doi-asserted-by":"publisher","first-page":"e0235461","DOI":"10.1371\/journal.pone.0235461","volume":"15","author":"SR Banala","year":"2020","unstructured":"Banala SR, Khattab OK, Page VD, Warneke CL, Todd KH, Yeung SJ. Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: a randomized controlled trial. PLoS ONE. 2020;15(7):e0235461. https:\/\/doi.org\/10.1371\/journal.pone.0235461.","journal-title":"PLoS ONE"},{"issue":"3","key":"289_CR228","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10717540500455975","volume":"13","author":"MB Brown","year":"2006","unstructured":"Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery. 2006;13(3):175\u201387. https:\/\/doi.org\/10.1080\/10717540500455975.","journal-title":"Drug Delivery"},{"issue":"35","key":"289_CR229","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2174\/0113816128305190240718112945","volume":"30","author":"Y Song","year":"2024","unstructured":"Song Y, Chen W, Yin Y, Li J, Wang M, Liu Y, et al. Advancements in the transdermal drug delivery systems utilizing microemulsion-based gels. Curr Pharm Des. 2024;30(35):2753\u201364. https:\/\/doi.org\/10.2174\/0113816128305190240718112945.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"289_CR230","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261\u20138. https:\/\/doi.org\/10.1038\/nbt.1504.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"289_CR231","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ejpb.2013.01.018","volume":"84","author":"ME Lane","year":"2013","unstructured":"Lane ME. The transdermal delivery of fentanyl. Eur J Pharmaceut Biopharmaceut. 2013;84(3):449\u201355. https:\/\/doi.org\/10.1016\/j.ejpb.2013.01.018.","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"289_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurom.2024.08.006","author":"TR Deer","year":"2024","unstructured":"Deer TR, Hayek SM, Grider JS, Pope JE, Brogan SE, Gulati A, et al. The polyanalgesic consensus conference (PACC)\u00ae: updates on clinical pharmacology and comorbidity management in intrathecal drug delivery for cancer pain. Neuromodulation. 2024. https:\/\/doi.org\/10.1016\/j.neurom.2024.08.006.","journal-title":"Neuromodulation"},{"issue":"2","key":"289_CR233","first-page":"1","volume":"24","author":"Intrathecal Drug Delivery Systems for Cancer Pain","year":"2024","unstructured":"Intrathecal Drug Delivery Systems for Cancer Pain. A health technology assessment. Ontario Health Technol Assess Series. 2024;24(2):1\u2013162.","journal-title":"Ontario Health Technol Assess Series"},{"key":"289_CR234","doi-asserted-by":"publisher","unstructured":"Schultz DM, Bakke CH, Ruble HL, Larmour CS, Hagedorn JM, Abd-Elsayed A. Intrathecal drug delivery for intractable pain: identified patient satisfaction survey study comparing intrathecal dose with satisfaction, pain relief, and side effects. Neuromodulation: Technology at the Neural Interface. 2025. https:\/\/doi.org\/10.1016\/j.neurom.2024.11.006.","DOI":"10.1016\/j.neurom.2024.11.006"},{"issue":"6","key":"289_CR235","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.neurom.2022.03.003","volume":"26","author":"R Duarte","year":"2023","unstructured":"Duarte R, Copley S, Nevitt S, Maden M, Al-Ali AM, Dupoiron D, et al. Effectiveness and safety of intrathecal drug delivery systems for the management of cancer pain: a systematic review and meta-analysis. Neuromodulation. 2023;26(6):1126\u201341. https:\/\/doi.org\/10.1016\/j.neurom.2022.03.003.","journal-title":"Neuromodulation"},{"issue":"6","key":"289_CR236","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.neurom.2021.12.004","volume":"26","author":"C Perruchoud","year":"2023","unstructured":"Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan SE. Management of cancer-related pain with intrathecal drug delivery: a systematic review and meta-analysis of clinical studies. Neuromodulation. 2023;26(6):1142\u201352. https:\/\/doi.org\/10.1016\/j.neurom.2021.12.004.","journal-title":"Neuromodulation"},{"issue":"9516","key":"289_CR237","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/s0140-6736(06)68307-4","volume":"367","author":"GP Zaloga","year":"2006","unstructured":"Zaloga GP. Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: assessment of outcomes. Lancet (London, England). 2006;367(9516):1101\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(06)68307-4.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"289_CR238","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jointm.2021.11.006","volume":"2","author":"MM Berger","year":"2022","unstructured":"Berger MM, Pichard C. When is parenteral nutrition indicated? J Intens Med. 2022;2(1):22\u20138. https:\/\/doi.org\/10.1016\/j.jointm.2021.11.006.","journal-title":"J Intens Med"},{"key":"289_CR239","doi-asserted-by":"publisher","unstructured":"Rozman de Moraes A, Erdogan E, Azhar A, Reddy SK, Lu Z, Geller JA et al. scheduled and breakthrough opioid use for cancer pain in an inpatient setting at a tertiary cancer hospital. Curr Oncol (Toronto, Ont). 2024;31(3):1335-47. https:\/\/doi.org\/10.3390\/curroncol31030101.","DOI":"10.3390\/curroncol31030101"},{"issue":"6","key":"289_CR240","first-page":"588","volume":"8","author":"RJ Wickham","year":"2017","unstructured":"Wickham RJ. Cancer pain management: opioid analgesics, part 2. J Adv Pract Oncol. 2017;8(6):588\u2013607.","journal-title":"J Adv Pract Oncol"},{"key":"289_CR241","doi-asserted-by":"publisher","unstructured":"Anusha A, Ponnekanti K, Tiwari R, Swapna L, Hussain M, Siddhardha A. A review of medicines with sustained release. World J Biol Pharmacy Health Sci. 2023;13:221\u201333. https:\/\/doi.org\/10.30574\/wjbphs.2023.13.3.0141.","DOI":"10.30574\/wjbphs.2023.13.3.0141"},{"issue":"8","key":"289_CR242","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41401-024-01255-2","volume":"45","author":"RJ Mu","year":"2024","unstructured":"Mu RJ, Liu TL, Liu XD, Liu L. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans. Acta Pharmacol Sin. 2024;45(8):1752\u201364. https:\/\/doi.org\/10.1038\/s41401-024-01255-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"289_CR243","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1517\/14656566.2011.521743","volume":"12","author":"F Lui","year":"2011","unstructured":"Lui F, Ng KF. Adjuvant analgesics in acute pain. Expert Opin Pharmacother. 2011;12(3):363\u201385. https:\/\/doi.org\/10.1517\/14656566.2011.521743.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"289_CR244","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.pain.2011.01.005","volume":"152","author":"M Von Korff","year":"2011","unstructured":"Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011;152(6):1256\u201362. https:\/\/doi.org\/10.1016\/j.pain.2011.01.005.","journal-title":"Pain."},{"key":"289_CR245","doi-asserted-by":"publisher","unstructured":"Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, et al. Dosing frequency and medication adherence in chronic disease. Journal of managed care pharmacy. 2012;18(7):527\u201339. https:\/\/doi.org\/10.18553\/jmcp.2012.18.7.527.","DOI":"10.18553\/jmcp.2012.18.7.527"},{"issue":"1","key":"289_CR246","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1353\/hpu.2023.0013","volume":"34","author":"AM Russell","year":"2023","unstructured":"Russell AM, Opsasnick L, Weiner-Light S, Bailey SC, O\u2019Brien M, Wolf MS. Medication dosing schedules, medication knowledge, and dosing errors of adults taking complex drug regimens. J Health Care Poor Underserved. 2023;34(1):192\u2013207. https:\/\/doi.org\/10.1353\/hpu.2023.0013.","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"289_CR247","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1756-9966-29-67","volume":"29","author":"Q Yang","year":"2010","unstructured":"Yang Q, Xie DR, Jiang ZM, Ma W, Zhang YD, Bi ZF, et al. Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysis. J Exper Clin Cancer Res. 2010;29(1):67. https:\/\/doi.org\/10.1186\/1756-9966-29-67.","journal-title":"J Exper Clin Cancer Res"},{"issue":"Suppl 2","key":"289_CR248","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1526-4637.2009.00666.x","volume":"10","author":"PG Fine","year":"2009","unstructured":"Fine PG, Mahajan G, McPherson ML. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain medicine (Malden, Mass). 2009;10(Suppl 2):S79-88. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00666.x.","journal-title":"Pain medicine (Malden, Mass)"},{"key":"289_CR249","doi-asserted-by":"crossref","unstructured":"Oldham JM. Opioids. Journal of Psychiatric Practice\u00ae. 2020;26(1).","DOI":"10.1097\/PRA.0000000000000444"},{"key":"289_CR250","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/164_2018_149","volume":"252","author":"PM Beardsley","year":"2018","unstructured":"Beardsley PM, Zhang Y. Synthetic Opioids. Handb Exp Pharmacol. 2018;252:353\u201381. https:\/\/doi.org\/10.1007\/164_2018_149.","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"289_CR251","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0310057x1204000204","volume":"40","author":"BA Baldo","year":"2012","unstructured":"Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care. 2012;40(2):216\u201335. https:\/\/doi.org\/10.1177\/0310057x1204000204.","journal-title":"Anaesth Intensive Care"},{"key":"289_CR252","doi-asserted-by":"publisher","unstructured":"Gengo PJ, Pettit HO, O'Neill SJ, Wei K, McNutt R, Bishop MJ et al. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity. The Journal of pharmacology and experimental therapeutics. 2003;307(3):1221\u20136. https:\/\/doi.org\/10.1124\/jpet.103.054361.","DOI":"10.1124\/jpet.103.054361"},{"issue":"1","key":"289_CR253","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","volume":"341","author":"C Mollereau","year":"1994","unstructured":"Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS letters. 1994;341(1):33\u20138. https:\/\/doi.org\/10.1016\/0014-5793(94)80235-1.","journal-title":"FEBS letters."},{"key":"289_CR254","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2014.00262","volume":"5","author":"GL Thompson","year":"2014","unstructured":"Thompson GL, Canals M, Poole DP. Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity. Front Pharmacol. 2014;5:262. https:\/\/doi.org\/10.3389\/fphar.2014.00262.","journal-title":"Front Pharmacol"},{"issue":"6","key":"289_CR255","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363\u201381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6.","journal-title":"Anesthesiology"},{"issue":"1","key":"289_CR256","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s42003-024-07084-7","volume":"7","author":"J Chen","year":"2024","unstructured":"Chen J, Putkinen V, Sepp\u00e4l\u00e4 K, Hirvonen J, Ioumpa K, Gazzola V, et al. Endogenous opioid receptor system mediates costly altruism in the human brain. Communications biology. 2024;7(1):1401. https:\/\/doi.org\/10.1038\/s42003-024-07084-7.","journal-title":"Communications biology"},{"issue":"2","key":"289_CR257","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/theoncologist.2012-0269","volume":"18","author":"A Reddy","year":"2013","unstructured":"Reddy A, Yennurajalingam S, Pulivarthi K, Palla SL, Wang X, Kwon JH, et al. Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids. Oncologist. 2013;18(2):212\u201320. https:\/\/doi.org\/10.1634\/theoncologist.2012-0269.","journal-title":"Oncologist"},{"issue":"6","key":"289_CR258","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/106002808301700601","volume":"17","author":"EM Zola","year":"1983","unstructured":"Zola EM, McLeod DC. Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell Clin Pharm. 1983;17(6):411\u20137. https:\/\/doi.org\/10.1177\/106002808301700601.","journal-title":"Drug Intell Clin Pharm"},{"issue":"3","key":"289_CR259","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","volume":"41","author":"PJ Hoskin","year":"1991","unstructured":"Hoskin PJ, Hanks GW. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs. 1991;41(3):326\u201344. https:\/\/doi.org\/10.2165\/00003495-199141030-00002.","journal-title":"Drugs"},{"issue":"5","key":"289_CR260","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/j.jpainsymman.2023.06.022","volume":"66","author":"M Chwistek","year":"2023","unstructured":"Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain? J Pain Symptom Manage. 2023;66(5):e638\u201343. https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.022.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"289_CR261","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/adm.0000000000000457","volume":"13","author":"MA Coe","year":"2019","unstructured":"Coe MA, Lofwall MR, Walsh SL. Buprenorphine pharmacology review: update on transmucosal and long-acting formulations. J Addict Med. 2019;13(2):93\u2013103. https:\/\/doi.org\/10.1097\/adm.0000000000000457.","journal-title":"J Addict Med"},{"issue":"1","key":"289_CR262","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-9966-28-61","volume":"28","author":"C Aurilio","year":"2009","unstructured":"Aurilio C, Pace MC, Pota V, Sansone P, Barbarisi M, Grella E, et al. Opioids switching with transdermal systems in chronic cancer pain. J Exp Clin Cancer Res. 2009;28(1):61. https:\/\/doi.org\/10.1186\/1756-9966-28-61.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"289_CR263","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1185\/03007995.2012.678938","volume":"28","author":"RF Wolff","year":"2012","unstructured":"Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, et al. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin. 2012;28(5):833\u201345. https:\/\/doi.org\/10.1185\/03007995.2012.678938.","journal-title":"Curr Med Res Opin"},{"key":"289_CR264","doi-asserted-by":"publisher","unstructured":"Formenti P, Umbrello M, Pignataro M, Sabbatini G, Dottorini L, Gotti M et al. Managing Severe Cancer Pain with Oxycodone\/Naloxone Treatment: A Literature Review Update. Journal of personalized medicine. 2024;14(5). https:\/\/doi.org\/10.3390\/jpm14050483.","DOI":"10.3390\/jpm14050483"},{"key":"289_CR265","doi-asserted-by":"publisher","unstructured":"Wang S, Chen X, Han X, Hong X, Li X, Zhang H et al. A Review of 3D Printing Technology in Pharmaceutics: Technology and Applications, Now and Future. Pharmaceutics. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020416.","DOI":"10.3390\/pharmaceutics15020416"},{"issue":"1","key":"289_CR266","doi-asserted-by":"publisher","first-page":"e4764","DOI":"10.1002\/ejp.4764","volume":"29","author":"F Minnai","year":"2025","unstructured":"Minnai F, Shkodra M, Noci S, Esposito M, Brunelli C, Pigni A, et al. A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity. Eur J Pain (London, England). 2025;29(1):e4764. https:\/\/doi.org\/10.1002\/ejp.4764.","journal-title":"Eur J Pain (London, England)"},{"issue":"6610","key":"289_CR267","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384(6610):644\u20138. https:\/\/doi.org\/10.1038\/384644a0.","journal-title":"Nature"},{"issue":"3","key":"289_CR268","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","volume":"21","author":"GG Graham","year":"2013","unstructured":"Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201\u201332. https:\/\/doi.org\/10.1007\/s10787-013-0172-x.","journal-title":"Inflammopharmacology"},{"key":"289_CR269","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Valerie Gerriets declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"issue":"1","key":"289_CR270","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3121\/cmr.2007.698","volume":"5","author":"CK Ong","year":"2007","unstructured":"Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19\u201334. https:\/\/doi.org\/10.3121\/cmr.2007.698.","journal-title":"Clin Med Res"},{"issue":"7","key":"289_CR271","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.mpaic.2022.03.004","volume":"23","author":"E Casely","year":"2022","unstructured":"Casely E, Laycock H. Opioids in pain medicine. Anaesthes Intens Care Med. 2022;23(7):384\u201390. https:\/\/doi.org\/10.1016\/j.mpaic.2022.03.004.","journal-title":"Anaesthes Intens Care Med"},{"key":"289_CR272","doi-asserted-by":"crossref","unstructured":"Foley KM. Opioid Analgesics in Clinical Pain Management. In: Herz A, Akil H, Simon EJ, editors. Opioids II. Berlin, Heidelberg: Springer Berlin Heidelberg; 1993. p. 697\u2013743.","DOI":"10.1007\/978-3-642-77540-6_29"},{"key":"289_CR273","doi-asserted-by":"publisher","unstructured":"Obata H. Analgesic Mechanisms of Antidepressants for Neuropathic Pain. International journal of molecular sciences. 2017;18(11). https:\/\/doi.org\/10.3390\/ijms18112483.","DOI":"10.3390\/ijms18112483"},{"issue":"3","key":"289_CR274","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11916-001-0036-8","volume":"5","author":"TA Mays","year":"2001","unstructured":"Mays TA. Antidepressants in the management of cancer pain. Curr Pain Headache Rep. 2001;5(3):227\u201336. https:\/\/doi.org\/10.1007\/s11916-001-0036-8.","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"289_CR275","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","volume":"27","author":"JA Mic\u00f3","year":"2006","unstructured":"Mic\u00f3 JA, Ardid D, Berrocoso E, Eschalier A. Antidepressants and pain. Trends Pharmacol Sci. 2006;27(7):348\u201354. https:\/\/doi.org\/10.1016\/j.tips.2006.05.004.","journal-title":"Trends Pharmacol Sci"},{"key":"289_CR276","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","volume":"338","author":"M Kremer","year":"2016","unstructured":"Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Neuroscience. 2016;338:183\u2013206. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.06.057.","journal-title":"Neuroscience"},{"key":"289_CR277","doi-asserted-by":"publisher","unstructured":"Eija K, Tiina T, J NP. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996;64(2):293\u2013302. https:\/\/doi.org\/10.1016\/0304-3959(95)00138-7.","DOI":"10.1016\/0304-3959(95)00138-7"},{"issue":"8","key":"289_CR278","doi-asserted-by":"publisher","first-page":"e085438","DOI":"10.1136\/bmjopen-2024-085438","volume":"14","author":"S Hashemzadeh","year":"2024","unstructured":"Hashemzadeh S, Mortazavi M, Abdi DR. Quantitative analysis of nortriptyline\u2019s analgesic properties: a comparative systematic review and meta-analysis. BMJ Open. 2024;14(8):e085438. https:\/\/doi.org\/10.1136\/bmjopen-2024-085438.","journal-title":"BMJ Open"},{"issue":"3","key":"289_CR279","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.120.265082","volume":"373","author":"Y Lu","year":"2020","unstructured":"Lu Y, Zhang P, Zhang Q, Yang C, Qian Y, Suo J, et al. Duloxetine attenuates paclitaxel-induced peripheral nerve injury by inhibiting p53-related pathways. J Pharmacol Exp Ther. 2020;373(3):453\u201362. https:\/\/doi.org\/10.1124\/jpet.120.265082.","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"289_CR280","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359\u201367. https:\/\/doi.org\/10.1001\/jama.2013.2813.","journal-title":"JAMA"},{"issue":"5","key":"289_CR281","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/0897190013489573","volume":"26","author":"LJ Angelo","year":"2013","unstructured":"Angelo LJ, Lee KC. Dose-related paresthesias with venlafaxine. J Pharm Pract. 2013;26(5):514\u20137. https:\/\/doi.org\/10.1177\/0897190013489573.","journal-title":"J Pharm Pract"},{"key":"289_CR282","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fneur.2017.00307","volume":"8","author":"C Riediger","year":"2017","unstructured":"Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol. 2017;8:307. https:\/\/doi.org\/10.3389\/fneur.2017.00307.","journal-title":"Front Neurol"},{"key":"289_CR283","doi-asserted-by":"publisher","unstructured":"S\u00f6derpalm B. Anticonvulsants: aspects of their mechanisms of action. European journal of pain (London, England). 2002;6 Suppl A:3\u20139. https:\/\/doi.org\/10.1053\/eujp.2001.0315.","DOI":"10.1053\/eujp.2001.0315"},{"issue":"5","key":"289_CR284","doi-asserted-by":"publisher","first-page":"e786","DOI":"10.4317\/medoral.18001","volume":"17","author":"ML Vargas-Espinosa","year":"2012","unstructured":"Vargas-Espinosa ML, Sanmart\u00ed-Garc\u00eda G, V\u00e1zquez-Delgado E, Gay-Escoda C. Antiepileptic drugs for the treatment of neuropathic pain: a systematic review. Med Oral Patologia Oral y Cirugia Bucal. 2012;17(5):e786\u201393. https:\/\/doi.org\/10.4317\/medoral.18001.","journal-title":"Med Oral Patologia Oral y Cirugia Bucal"},{"issue":"6","key":"289_CR285","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41594-023-01013-8","volume":"30","author":"L Ferron","year":"2023","unstructured":"Ferron L, Gandini MA, Zamponi GW. Fighting pain: the structure of gabapentin and its binding site in the Ca(v)\u03b1(2)\u03b4 subunit. Nat Struct Mol Biol. 2023;30(6):717\u20139. https:\/\/doi.org\/10.1038\/s41594-023-01013-8.","journal-title":"Nat Struct Mol Biol"},{"issue":"14","key":"289_CR286","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1200\/jco.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol. 2004;22(14):2909\u201317. https:\/\/doi.org\/10.1200\/jco.2004.08.141.","journal-title":"J Clin Oncol"},{"issue":"6","key":"289_CR287","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0885-3924(99)00033-0","volume":"17","author":"A Caraceni","year":"1999","unstructured":"Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage. 1999;17(6):441\u20135. https:\/\/doi.org\/10.1016\/s0885-3924(99)00033-0.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"289_CR288","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10147-009-0009-1","volume":"15","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Shimoyama N. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin Oncol. 2010;15(1):46\u201351. https:\/\/doi.org\/10.1007\/s10147-009-0009-1.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"289_CR289","first-page":"E547","volume":"16","author":"M Nishihara","year":"2013","unstructured":"Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T, et al. Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician. 2013;16(5):E547\u201352.","journal-title":"Pain Physician"},{"issue":"9","key":"289_CR290","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00415-017-8465-4","volume":"264","author":"JM Keppel Hesselink","year":"2017","unstructured":"Keppel Hesselink JM. Phenytoin: a step by step insight into its multiple mechanisms of action-80 years of mechanistic studies in neuropharmacology. J Neurol. 2017;264(9):2043\u20137. https:\/\/doi.org\/10.1007\/s00415-017-8465-4.","journal-title":"J Neurol"},{"issue":"4","key":"289_CR291","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0885-3924(92)90077-u","volume":"7","author":"S Yajnik","year":"1992","unstructured":"Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a coanalgesic in cancer pain. J Pain Symptom Manage. 1992;7(4):209\u201313. https:\/\/doi.org\/10.1016\/0885-3924(92)90077-u.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"289_CR292","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0278-5846(03)00028-9","volume":"27","author":"IS Shiah","year":"2003","unstructured":"Shiah IS, Yatham LN, Gau YC, Baker GB. Effect of lamotrigine on plasma GABA levels in healthy humans. Progress Neuro-Psychopharmacol Biolog Psychiatry. 2003;27(3):419\u201323. https:\/\/doi.org\/10.1016\/S0278-5846(03)00028-9.","journal-title":"Progress Neuro-Psychopharmacol Biolog Psychiatry"},{"issue":"4","key":"289_CR293","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002508-200012000-00008","volume":"16","author":"GJ McCleane","year":"2000","unstructured":"McCleane GJ. Lamotrigine in the management of neuropathic pain: a review of the literature. Clin J Pain. 2000;16(4):321\u20136. https:\/\/doi.org\/10.1097\/00002508-200012000-00008.","journal-title":"Clin J Pain"},{"issue":"11","key":"289_CR294","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/j.pain.0000000000000266","volume":"156","author":"DT Demant","year":"2015","unstructured":"Demant DT, Lund K, Finnerup NB, Vollert J, Maier C, Segerdahl MS, et al. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study. Pain. 2015;156(11):2234\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000000266.","journal-title":"Pain"},{"issue":"1","key":"289_CR295","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12904-023-01126-3","volume":"22","author":"JH Tsai","year":"2023","unstructured":"Tsai JH, Liu IT, Su PF, Huang YT, Chiu GL, Chen YY, et al. Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment. BMC Palliat Care. 2023;22(1):4. https:\/\/doi.org\/10.1186\/s12904-023-01126-3.","journal-title":"BMC Palliat Care"},{"issue":"4","key":"289_CR296","doi-asserted-by":"publisher","first-page":"Cd010756","DOI":"10.1002\/14651858.CD010756.pub2","volume":"2015","author":"A Haywood","year":"2015","unstructured":"Haywood A, Good P, Khan S, Leupp A, Jenkins-Marsh S, Rickett K, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Datab Syst Rev. 2015;2015(4):Cd010756. https:\/\/doi.org\/10.1002\/14651858.CD010756.pub2.","journal-title":"Cochrane Datab Syst Rev"},{"issue":"4","key":"289_CR297","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11916-012-0273-z","volume":"16","author":"W Leppert","year":"2012","unstructured":"Leppert W, Buss T. The role of corticosteroids in the treatment of pain in cancer patients. Curr Pain Headache Rep. 2012;16(4):307\u201313. https:\/\/doi.org\/10.1007\/s11916-012-0273-z.","journal-title":"Curr Pain Headache Rep"},{"issue":"40","key":"289_CR298","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1523\/jneurosci.1173-17.2017","volume":"37","author":"NG Glasgow","year":"2017","unstructured":"Glasgow NG, Povysheva NV, Azofeifa AM, Johnson JW. Memantine and ketamine differentially Alter NMDA receptor desensitization. J Neurosci. 2017;37(40):9686\u2013704. https:\/\/doi.org\/10.1523\/jneurosci.1173-17.2017.","journal-title":"J Neurosci"},{"key":"289_CR299","unstructured":"Jamero D, Borghol A, Vo N, Hawawini F. The Emerging role of NMDA antagonists in pain management. US Pharmacist. 2011;36."},{"issue":"2","key":"289_CR300","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","volume":"28","author":"R Chou","year":"2004","unstructured":"Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28(2):140\u201375. https:\/\/doi.org\/10.1016\/j.jpainsymman.2004.05.002.","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"289_CR301","doi-asserted-by":"publisher","first-page":"e084500","DOI":"10.1136\/bmjopen-2024-084500","volume":"14","author":"L Ye","year":"2024","unstructured":"Ye L, Li YH, Huang YH, Deng QC, Huang YX, Peng YH, et al. Effectiveness of non-pharmacological interventions for pain management in patients with cancer:a protocol for systematic review and network meta-analysis. BMJ Open. 2024;14(10):e084500. https:\/\/doi.org\/10.1136\/bmjopen-2024-084500.","journal-title":"BMJ Open"},{"issue":"1","key":"289_CR302","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12916-023-03076-2","volume":"21","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wu W. Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress. BMC Med. 2023;21(1):372. https:\/\/doi.org\/10.1186\/s12916-023-03076-2.","journal-title":"BMC Med"},{"issue":"12","key":"289_CR303","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/s00520-012-1606-5","volume":"20","author":"JM Zhang","year":"2012","unstructured":"Zhang JM, Wang P, Yao JX, Zhao L, Davis MP, Walsh D, et al. Music interventions for psychological and physical outcomes in cancer: a systematic review and meta-analysis. Support Care Cancer. 2012;20(12):3043\u201353. https:\/\/doi.org\/10.1007\/s00520-012-1606-5.","journal-title":"Support Care Cancer"},{"issue":"10","key":"289_CR304","doi-asserted-by":"publisher","first-page":"Cd006911","DOI":"10.1002\/14651858.CD006911.pub4","volume":"10","author":"J Bradt","year":"2021","unstructured":"Bradt J, Dileo C, Myers-Coffman K, Biondo J. Music interventions for improving psychological and physical outcomes in people with cancer. Cochrane Datab Syst Rev. 2021;10(10):Cd006911. https:\/\/doi.org\/10.1002\/14651858.CD006911.pub4.","journal-title":"Cochrane Datab Syst Rev"},{"key":"289_CR305","doi-asserted-by":"publisher","first-page":"541","DOI":"10.29052\/IJEHSR.v9.i4.2021.541-554","volume":"9","author":"H Ameer Shaikh","year":"2021","unstructured":"Ameer Shaikh H, Anjum O, Iqbal K, Zaidi S. Effects of physiotherapy in the management of cancer-related pain and fatigue: a systematic review of randomized controlled trials. Int J Endors Health Sci Res (IJEHSR). 2021;9:541\u201354. https:\/\/doi.org\/10.29052\/IJEHSR.v9.i4.2021.541-554.","journal-title":"Int J Endors Health Sci Res (IJEHSR)."},{"key":"289_CR306","doi-asserted-by":"publisher","unstructured":"Leclerc AF, Foidart-Dessalle M, Tomasella M, Coucke P, Devos M, Bruy\u00e8re O et al. Multidisciplinary rehabilitation program after breast cancer: benefits on physical function, anthropometry and quality of life. European journal of physical and rehabilitation medicine. 2017;53(5):633\u201342. https:\/\/doi.org\/10.23736\/s1973-9087.17.04551-8.","DOI":"10.23736\/s1973-9087.17.04551-8"},{"issue":"4","key":"289_CR307","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jpainsymman.2015.11.027","volume":"51","author":"WW Tao","year":"2016","unstructured":"Tao WW, Jiang H, Tao XM, Jiang P, Sha LY, Sun XC. Effects of Acupuncture, Tuina, Tai Chi, Qigong, and traditional chinese medicine five-element music therapy on symptom management and quality of life for cancer patients: a meta-analysis. J Pain Symptom Manage. 2016;51(4):728\u201347. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.11.027.","journal-title":"J Pain Symptom Manage"},{"key":"289_CR308","doi-asserted-by":"publisher","unstructured":"He Y, Guo X, May B, Zhang T, Liu Y, Lu C-J et al. Clinical Evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis. JAMA Oncol. 2019;6. https:\/\/doi.org\/10.1001\/jamaoncol.2019.5233.","DOI":"10.1001\/jamaoncol.2019.5233"},{"issue":"2","key":"289_CR309","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/ner.13020","volume":"23","author":"M Hofmeister","year":"2020","unstructured":"Hofmeister M, Memedovich A, Brown S, Saini M, Dowsett LE, Lorenzetti DL, et al. Effectiveness of Neurostimulation technologies for the management of chronic pain: a systematic review. Neuromodulation. 2020;23(2):150\u20137. https:\/\/doi.org\/10.1111\/ner.13020.","journal-title":"Neuromodulation"},{"issue":"2","key":"289_CR310","first-page":"E131","volume":"24","author":"J Xu","year":"2021","unstructured":"Xu J, Sun Z, Wu J, Rana M, Garza J, Zhu AC, et al. Peripheral nerve stimulation in pain management: a systematic review. Pain Phys. 2021;24(2):E131\u201352.","journal-title":"Pain Phys"},{"key":"289_CR311","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00679-2","author":"Y Du","year":"2024","unstructured":"Du Y, Li Y, Hu J, Fang R, Liu Y, Cai L, et al. Repetitive Transcranial magnetic stimulation: is it an effective treatment for cancer pain? Pain Ther. 2024. https:\/\/doi.org\/10.1007\/s40122-024-00679-2.","journal-title":"Pain Ther"},{"issue":"3","key":"289_CR312","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer. 2002;2(3):201\u20139. https:\/\/doi.org\/10.1038\/nrc747.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"289_CR313","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13287-024-03828-8","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wu P, Wen Q. Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management. Stem Cell Res Ther. 2024;15(1):211. https:\/\/doi.org\/10.1186\/s13287-024-03828-8.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"289_CR314","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/spc.0000000000000140","volume":"9","author":"MR Brown","year":"2015","unstructured":"Brown MR, Ramirez JD. Neuroimmune mechanisms in cancer pain. Curr Opin Support Palliat Care. 2015;9(2):103\u201311. https:\/\/doi.org\/10.1097\/spc.0000000000000140.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"289_CR315","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12630-014-0275-x","volume":"62","author":"M Tan","year":"2015","unstructured":"Tan M, Law LS, Gan TJ. Optimizing pain management to facilitate enhanced recovery after surgery pathways. Canadian J Anaesthesia J Canadien d\u2019anesthesie. 2015;62(2):203\u201318. https:\/\/doi.org\/10.1007\/s12630-014-0275-x.","journal-title":"Canadian J Anaesthesia J Canadien d'anesthesie"},{"key":"289_CR316","unstructured":"Sampognaro G, Harrell R. Multimodal Postoperative Pain Control After Orthopaedic Surgery. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Richard Harrell declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"289_CR317","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2024.11.021","author":"AV Nguyen","year":"2024","unstructured":"Nguyen AV, Soto JM, Keith KA, Lyon KA, Rahm MD, Huang JH. Ropivacaine-epinephrine-clonidine-ketorolac is an effective opioid-sparing local anesthetic for patients undergoing posterior spinal fusion. Spine J. 2024. https:\/\/doi.org\/10.1016\/j.spinee.2024.11.021.","journal-title":"Spine J"},{"issue":"14","key":"289_CR318","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/brs.0000000000001443","volume":"42","author":"AP Perera","year":"2017","unstructured":"Perera AP, Chari A, Kostusiak M, Khan AA, Luoma AM, Casey ATH. Intramuscular local anesthetic infiltration at closure for postoperative analgesia in lumbar spine surgery: a systematic review and meta-analysis. Spine. 2017;42(14):1088\u201395. https:\/\/doi.org\/10.1097\/brs.0000000000001443.","journal-title":"Spine"},{"issue":"2","key":"289_CR319","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","volume":"34","author":"K Keskinbora","year":"2007","unstructured":"Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manag. 2007;34(2):183\u20139. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.11.013.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"289_CR320","doi-asserted-by":"publisher","first-page":"637","DOI":"10.21037\/tcr-20-2692","volume":"10","author":"H Bao","year":"2021","unstructured":"Bao H, Wu Z, Wang Q, Wang J, Zhang L, Meng L, et al. The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis. Translatl Cancer Res. 2021;10(2):637\u201344. https:\/\/doi.org\/10.21037\/tcr-20-2692.","journal-title":"Translatl Cancer Res"},{"issue":"3","key":"289_CR321","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3349\/ymj.2012.53.3.649","volume":"53","author":"YS Jeon","year":"2012","unstructured":"Jeon YS, Lee JA, Choi JW, Kang EG, Jung HS, Kim HK, et al. Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study. Yonsei Med J. 2012;53(3):649\u201353. https:\/\/doi.org\/10.3349\/ymj.2012.53.3.649.","journal-title":"Yonsei Med J"},{"issue":"1","key":"289_CR322","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpa.2020.12.001","volume":"35","author":"N Rawal","year":"2021","unstructured":"Rawal N. Epidural analgesia for postoperative pain: Improving outcomes or adding risks? Best Pract Res Clin Anaesthesiol. 2021;35(1):53\u201365. https:\/\/doi.org\/10.1016\/j.bpa.2020.12.001.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"289_CR323","doi-asserted-by":"publisher","first-page":"107363","DOI":"10.1016\/j.cct.2023.107363","volume":"135","author":"HM Fisher","year":"2023","unstructured":"Fisher HM, Check DK, Somers TJ, Kelleher SA, Majestic C, Yu JA, et al. Meaning-centered pain coping skills training for patients with metastatic cancer: protocol for a randomized controlled efficacy trial. Contemp Clin Trials. 2023;135:107363. https:\/\/doi.org\/10.1016\/j.cct.2023.107363.","journal-title":"Contemp Clin Trials"},{"key":"289_CR324","doi-asserted-by":"publisher","first-page":"103709","DOI":"10.1016\/j.critrevonc.2022.103709","volume":"175","author":"KG Blumenstein","year":"2022","unstructured":"Blumenstein KG, Brose A, Kemp C, Meister D, Walling E, DuVall AS, et al. Effectiveness of cognitive behavioral therapy in improving functional health in cancer survivors: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2022;175:103709. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103709.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"289_CR325","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.pmn.2017.11.010","volume":"19","author":"MO Ezenwa","year":"2018","unstructured":"Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Dyal B, et al. Differences in sensory pain, expectation, and satisfaction reported by outpatients with cancer or sickle cell disease. Pain Manag Nurs. 2018;19(4):322\u201332. https:\/\/doi.org\/10.1016\/j.pmn.2017.11.010.","journal-title":"Pain Manag Nurs"},{"key":"289_CR326","doi-asserted-by":"publisher","unstructured":"Raad M, L\u00f3pez WOC, Sharafshah A, Assefi M, Lewandrowski KU. Personalized Medicine in Cancer Pain Management. Journal of personalized medicine. 2023;13(8). https:\/\/doi.org\/10.3390\/jpm13081201.","DOI":"10.3390\/jpm13081201"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00289-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:02:55Z","timestamp":1751050975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00289-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":326,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00289-0","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}